rfhg_223389.1

Basic information about the TSS

---

TSS ID: rfhg_223389.1 Species: human Chr: chr20		Start: 63741270 End: 63741300 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D3322156,EH38E2129609)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000493772.5:-18 BC017446:-18 GeneID: 56731 HGNC/MGI_ID: HGNC:15930 UniProt_ID: Nearer transcript ids and distances: ENST00000491109.1:104 AK298304:-159 view more...

Gene_name: SLC2A4 regulator Gene_symbol: SLC2A4RG Gene_synonyms: GEF HDBP1 Si-1-2 Si-1-2-19 Gene_source: HGNC:15930

TATA-Box annotation

---

Distance to TSS:	1509
Nearest PromoterID:	NM_020062
Entrez ID:	56731
Nearest Unigene:	Hs.435126
Nearest Refseq:	NM_020062
Nearest Ensembl:	ENSG00000125520
Gene Name:	SLC2A4 regulator
Gene Alias:	GEF|HDBP-1|HDBP1|Si-1-2|Si-1-2-19
Gene Type:	protein-coding
CpG%:	0.066667
GC%:	0.741935
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@SLC2A4RG p2@SLC2A4RG p3@SLC2A4RG p4@SLC2A4RG p5@SLC2A4RG p6@SLC2A4RG p7@SLC2A4RG p9@SLC2A4RG
Sample		p1@SLC2A4RG	p2@SLC2A4RG	p3@SLC2A4RG	p4@SLC2A4RG	p5@SLC2A4RG	p6@SLC2A4RG	p7@SLC2A4RG	p9@SLC2A4RG
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	3.12	3.51	3.31	4.87	0.19	0.39	0.97	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	3.44	3.84	3.03	3.03	0.20	0.40	1.21	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	2.51	3.09	2.70	4.05	0.00	0.19	0.96	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	2.91	2.08	0.62	1.87	0.21	0.21	0.42	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	3.15	1.80	2.92	3.37	0.22	0.22	0.45	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	3.68	3.10	2.52	1.74	0.19	0.58	1.36	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	1.96	3.27	3.05	3.49	0.00	0.87	0.22	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	1.70	2.42	3.39	4.60	0.00	0.73	0.73	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	2.99	4.06	3.21	3.21	0.00	1.28	0.43	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	3.48	5.80	1.74	2.32	0.58	1.16	0.58	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	0.81	10.11	3.23	4.04	0.00	1.62	1.21	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	1.22	9.76	2.85	4.07	0.00	0.41	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	21.92	7.09	5.16	8.22	0.16	1.61	0.97	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	14.73	7.97	3.61	7.52	0.00	1.20	1.20	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	17.13	5.71	2.63	9.88	0.00	0.88	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	19.11	4.02	5.28	9.81	0.00	1.01	0.75	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	16.16	4.80	3.93	6.77	0.22	0.87	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	8.44	3.80	0.84	7.17	0.00	0.00	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	10.13	4.80	0.53	11.73	1.07	0.53	0.53	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	16.85	5.57	3.31	7.07	0.00	0.90	1.05	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	18.31	7.89	3.34	6.82	0.40	1.07	0.80	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	16.57	3.28	2.93	9.67	0.17	0.69	0.17	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	16.03	5.30	3.10	8.92	0.39	1.29	0.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	16.50	5.34	2.18	6.79	0.73	1.21	0.49	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	16.51	4.39	3.10	7.22	0.00	1.29	0.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	16.78	1.58	4.11	8.55	0.32	0.63	1.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	9.34	3.30	4.40	11.54	0.00	1.10	0.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	15.80	6.60	3.30	8.96	0.47	1.89	1.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	17.12	4.68	4.04	6.30	0.00	0.65	1.29	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	19.91	5.25	3.62	7.06	0.18	1.09	0.72	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	15.70	4.81	4.40	5.86	0.42	0.84	0.63	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	14.65	3.32	3.52	5.28	0.20	0.78	0.59	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	13.08	6.33	1.90	8.44	0.21	0.63	1.69	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	6.27	3.63	1.98	7.92	0.16	0.33	0.99	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	14.21	5.05	2.80	6.92	0.00	1.68	1.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	17.25	7.09	2.30	5.56	0.19	0.57	0.57	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	16.96	3.47	3.68	7.97	0.00	0.61	1.43	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	15.31	4.23	4.03	7.86	0.40	0.40	1.21	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	17.56	3.78	2.43	10.80	0.27	0.81	0.54	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	13.68	2.40	2.64	6.24	0.24	1.20	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	15.53	2.82	3.29	5.88	0.24	0.47	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	8.78	2.49	1.61	6.88	0.29	1.17	1.61	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	14.34	3.16	2.11	9.07	0.21	0.84	0.42	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	16.08	3.50	3.67	5.42	0.17	0.52	1.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	16.66	2.41	2.21	5.22	0.00	0.60	0.60	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	18.15	3.72	3.49	5.82	0.00	1.16	0.93	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	15.11	2.88	2.16	4.56	0.00	0.96	0.96	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	18.48	3.28	3.28	4.77	0.00	0.30	0.30	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	18.43	1.44	2.63	5.27	0.00	1.44	0.72	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	11.73	4.25	1.62	3.64	0.20	1.01	0.81	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	11.07	1.84	1.43	10.66	0.61	0.82	0.61	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	12.01	1.33	2.45	7.78	0.00	0.44	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	0.00	0.00	27.98	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	14.19	2.48	1.42	9.58	0.00	0.71	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	15.58	0.99	2.32	9.61	0.33	0.66	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	3.36	5.87	1.68	26.85	0.00	0.00	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	2.30	1.84	2.30	19.75	0.00	0.46	1.38	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	12.32	1.94	1.62	11.67	0.00	0.97	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	13.81	1.93	3.53	7.39	0.00	1.61	1.28	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	4.40	1.26	0.63	16.35	0.00	0.63	0.94	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	16.92	0.71	1.41	7.05	0.00	0.00	2.12	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	15.14	1.12	2.24	3.93	0.00	1.12	1.12	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	2.39	2.39	2.39	14.33	0.00	1.59	3.98	1.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	5.44	3.06	1.02	10.87	0.00	0.00	1.70	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	14.30	1.95	3.25	7.15	0.00	0.65	1.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	18.81	2.84	3.19	8.16	0.00	1.77	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	7.90	31.59	0.00	47.38	0.00	0.00	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	15.60	3.41	5.85	11.21	0.98	0.98	2.93	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	15.37	3.47	4.96	14.38	0.00	0.00	1.98	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	9.85	2.35	4.22	7.97	0.00	0.00	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	7.95	1.66	3.64	14.57	0.00	0.33	1.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	17.01	3.09	4.33	10.83	0.31	0.93	1.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	18.65	2.75	3.97	7.95	0.00	0.61	0.61	0.00
Adipocyte - breast, donor1	11376-118A8	5.07	1.58	0.95	1.27	0.00	0.63	0.00	0.00
Adipocyte - breast, donor2	11327-117E4	8.50	1.76	2.09	6.90	0.48	0.32	0.32	0.96
Adipocyte - omental, donor1	11473-119C6	4.33	1.02	0.89	1.02	0.13	0.25	0.00	0.25
Adipocyte - omental, donor2	11474-119C7	5.23	2.24	0.75	3.74	0.00	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	6.03	3.01	0.33	4.02	0.33	0.00	0.00	0.67
Adipocyte - perirenal, donor1	11476-119C9	3.19	0.64	0.00	1.91	0.00	0.64	0.64	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	12.09	2.20	4.40	11.00	0.00	2.20	3.30	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	11.29	4.52	3.61	0.90	0.00	0.90	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	24.33	7.65	4.34	2.61	1.56	3.48	2.61	1.56
Adipocyte differentiation, day04, donor1	13019-139D4	27.97	8.41	7.63	1.96	0.98	0.98	0.39	2.15
Adipocyte differentiation, day04, donor2	13022-139D7	3.35	3.09	1.03	3.60	0.77	0.77	0.26	1.03
Adipocyte differentiation, day04, donor3	13025-139E1	12.27	11.43	6.97	3.90	0.56	0.84	0.84	2.23
Adipocyte differentiation, day04, donor4	13028-139E4	12.34	7.05	4.11	7.05	2.35	1.18	1.18	1.76
Adipocyte differentiation, day08, donor1	13020-139D5	32.25	9.01	7.72	5.23	5.39	4.58	0.56	11.66
Adipocyte differentiation, day08, donor2	13023-139D8	3.23	4.52	1.29	0.97	1.29	1.61	0.65	3.55
Adipocyte differentiation, day08, donor3	13026-139E2	6.93	2.67	3.20	9.60	2.13	2.67	0.53	5.33
Adipocyte differentiation, day08, donor4	13029-139E5	6.12	4.45	0.56	7.23	0.56	0.00	0.56	1.67
Adipocyte differentiation, day12, donor1	13021-139D6	18.72	5.41	6.65	7.90	3.74	6.24	1.66	9.98
Adipocyte differentiation, day12, donor2	13024-139D9	9.04	2.51	1.76	5.02	0.75	1.00	0.75	5.02
Adipocyte differentiation, day12, donor3	13027-139E3	10.47	4.58	6.22	10.47	3.27	2.29	0.65	6.22
Adipocyte differentiation, day12, donor4	13030-139E6	12.79	2.74	3.35	4.57	2.74	2.44	1.52	3.04
Alveolar Epithelial Cells, donor1	11510-119G7	11.71	6.41	8.62	1.10	0.00	0.88	0.22	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	13.98	11.12	26.89	3.94	0.36	1.43	1.43	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	9.58	13.18	9.58	2.40	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	20.33	6.48	11.15	1.80	0.00	1.80	0.36	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	11.71	8.37	11.71	8.37	0.00	1.67	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	24.86	10.07	12.12	5.96	0.00	1.44	1.44	0.00
Anulus Pulposus Cell, donor1	11248-116E6	7.55	9.84	6.87	1.49	1.83	1.14	1.49	0.92
Anulus Pulposus Cell, donor2	11463-119B5	5.63	6.61	6.37	2.20	0.73	0.98	2.20	0.98
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	5.39	4.49	7.19	5.39	0.90	0.45	1.80	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	6.08	3.91	7.81	9.12	0.00	0.87	0.87	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	4.28	0.00	8.56	6.42	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	5.98	4.48	3.29	9.27	0.60	0.60	0.90	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	2.53	3.79	5.06	5.06	0.00	1.26	3.79	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	3.96	1.32	10.56	7.26	0.00	1.32	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	6.17	3.90	4.87	7.80	0.32	0.32	0.65	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	3.40	5.34	3.88	2.91	0.00	1.46	1.94	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	4.16	3.56	6.53	6.53	0.59	0.59	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	7.53	4.14	3.77	5.27	0.00	0.38	2.64	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	6.53	5.08	5.81	5.08	0.73	1.45	2.18	1.45
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	7.52	1.25	6.27	8.78	2.51	0.00	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	8.73	3.79	4.94	2.64	0.49	1.48	0.00	0.66
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	5.46	2.73	2.73	8.19	0.00	1.36	2.73	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	6.03	2.41	4.67	1.06	0.45	0.60	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	4.29	6.97	7.50	6.43	0.00	1.07	2.14	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	6.99	4.91	6.61	4.53	0.00	0.38	1.89	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	5.61	2.14	4.01	6.95	0.00	1.34	1.07	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	6.83	0.98	6.83	6.83	0.98	0.98	1.95	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	8.46	3.15	7.13	3.98	0.83	1.49	1.82	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	6.00	1.20	4.80	8.41	0.00	1.20	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	0.00	0.00	7.08	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	8.40	4.12	6.69	4.63	0.34	1.03	1.54	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	0.00	4.19	0.00	4.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	4.85	3.88	10.68	3.88	0.49	1.94	0.97	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	11.38	4.55	7.59	5.31	0.00	0.00	1.90	0.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	1.21	1.21	9.69	2.42	1.21	0.00	2.42	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	2.85	6.27	6.27	9.69	0.00	0.00	1.71	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	6.20	4.28	8.12	5.99	0.43	0.64	1.07	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	6.97	4.13	7.23	6.19	1.55	1.03	1.55	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	7.98	5.16	5.16	3.75	0.00	0.94	3.28	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	5.47	4.18	3.86	1.93	0.32	1.29	0.96	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	3.57	2.85	6.42	7.13	0.00	2.14	1.43	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	2.92	8.77	5.26	4.68	1.17	0.00	1.75	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	9.03	2.41	4.52	3.91	0.30	0.90	0.90	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	5.94	3.56	5.94	5.94	0.00	0.00	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	10.17	4.58	8.14	10.68	0.51	0.00	2.03	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	7.64	4.33	5.35	2.80	1.02	1.02	0.76	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	3.18	1.91	4.45	5.72	0.00	0.64	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	5.18	3.88	7.77	7.34	0.43	1.29	1.73	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	7.62	4.23	7.20	2.12	0.21	0.21	1.69	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	5.51	4.06	6.96	3.48	0.29	0.58	0.87	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	5.67	6.61	12.28	5.67	0.00	2.83	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	8.98	3.73	7.97	3.39	0.34	1.70	0.51	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	6.95	4.63	4.63	13.90	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	2.11	10.56	8.45	10.56	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	5.79	3.86	8.36	5.15	0.43	0.64	1.93	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	4.21	1.80	3.61	9.63	0.00	1.20	2.41	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	5.10	5.10	2.92	4.37	0.00	0.73	3.64	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	7.59	2.99	6.44	3.68	0.23	1.15	1.84	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	5.10	5.10	2.55	5.10	0.00	0.00	2.55	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	4.32	2.29	2.29	1.27	0.25	0.51	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	8.67	2.89	6.81	2.89	0.21	1.03	1.03	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	6.73	2.45	5.81	6.12	1.53	0.31	1.84	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	1.91	4.30	3.35	5.26	0.00	0.96	2.87	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	7.76	2.44	4.66	4.88	0.22	0.89	1.77	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	6.10	3.05	6.10	4.58	0.00	0.00	3.05	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	2.22	3.88	3.88	3.32	0.00	0.55	3.32	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	6.62	2.91	5.03	4.77	0.00	1.06	1.06	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	3.27	1.09	5.45	4.00	0.36	0.36	0.73	0.00
Astrocyte - cerebellum, donor1	11500-119F6	11.18	6.39	8.47	1.60	0.74	1.84	0.86	0.37
Astrocyte - cerebellum, donor2	11580-120F5	22.42	8.73	13.86	4.45	0.34	1.20	1.54	0.51
Astrocyte - cerebellum, donor3	11661-122F5	17.20	7.76	6.08	3.99	0.42	1.05	2.10	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	15.34	9.06	5.93	0.35	0.35	0.35	1.39	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	20.22	7.44	12.78	9.22	0.00	1.29	1.62	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	20.14	7.16	8.05	5.82	0.00	0.30	0.75	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	4.70	1.83	0.69	2.06	0.00	0.00	0.46	0.23
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	5.89	1.63	1.25	1.13	0.00	0.38	0.13	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	5.01	2.62	1.14	0.68	0.00	0.23	0.23	0.00
Basophils, donor1	12241-129G9	4.18	2.09	3.66	0.00	0.00	0.00	0.00	0.00
Basophils, donor2	12242-129H1	3.61	3.25	3.61	1.08	0.00	0.00	0.36	0.00
Basophils, donor3	12243-129H2	9.55	3.38	2.35	0.15	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	10.13	15.52	9.06	1.94	0.43	1.08	0.43	0.86
Bronchial Epithelial Cell, donor2	11591-120G7	23.32	20.57	32.46	15.09	0.00	2.74	3.20	1.37
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	7.17	14.35	0.00	0.00	0.00	7.17	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	11.93	7.53	15.06	1.88	0.63	1.26	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	16.01	12.89	19.55	2.08	0.42	2.29	0.42	0.83
Bronchial Epithelial Cell, donor6	11461-119B3	9.90	19.80	17.50	2.99	0.00	2.07	2.07	0.92
Bronchial Epithelial Cell, donor7	11769-123I5	11.52	13.32	10.62	7.20	0.00	1.26	1.98	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	2.89	0.00	0.10	0.10	0.00	0.00	0.00	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	4.19	0.00	0.00	0.70	0.00	0.23	0.23	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	18.23	4.16	15.35	1.92	0.32	0.32	0.32	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	10.34	0.00	10.34	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	6.20	2.25	2.25	0.56	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	4.08	3.34	1.67	0.37	0.00	0.19	0.19	0.00
CD14+ Monocytes, donor3	11381-118B4	6.59	3.73	3.95	1.10	0.00	0.22	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	5.38	2.26	1.13	0.85	0.00	0.28	0.00	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	5.31	1.14	0.76	0.00	0.00	0.00	0.00	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	2.96	2.30	1.64	0.33	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	3.76	1.45	0.43	2.02	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	1.81	0.60	0.00	1.51	0.00	0.00	0.30	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	4.97	1.18	1.18	2.61	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	1.51	0.33	0.33	2.18	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	1.66	0.00	0.28	0.55	0.00	0.83	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	3.22	0.74	0.25	0.74	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	3.33	0.78	0.39	1.76	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	2.31	1.42	1.25	1.42	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	1.74	0.87	0.22	2.39	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	3.28	0.94	0.00	0.23	0.00	0.23	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	5.81	1.06	0.00	0.00	0.00	0.53	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	2.22	1.11	0.00	1.11	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	3.72	1.34	0.45	2.38	0.00	0.15	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	1.80	0.80	0.80	1.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	2.29	0.83	0.00	1.25	0.00	0.00	0.21	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	3.66	0.23	0.46	2.06	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	2.94	1.58	0.90	0.45	0.00	0.45	0.00	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	1.31	1.75	0.44	1.31	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	4.03	1.34	0.54	2.96	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	6.98	1.74	0.70	3.14	0.00	0.00	0.17	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	3.37	1.26	0.84	1.68	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	1.47	0.55	0.55	0.92	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	1.41	0.35	0.00	1.06	0.00	0.35	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	1.75	1.32	0.44	1.32	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	3.31	1.74	0.00	1.92	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	4.83	1.86	0.74	1.49	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	1.72	2.16	1.08	3.23	0.00	0.00	0.43	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	3.28	0.00	3.28	2.05	0.00	0.41	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	1.62	1.16	0.70	1.16	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	2.32	0.46	0.00	0.23	0.00	0.23	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	1.31	0.65	0.44	1.09	0.22	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	3.00	1.15	0.23	0.92	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	3.25	1.08	0.22	0.43	0.00	0.00	0.22	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	4.98	5.14	0.78	1.87	0.00	0.16	0.16	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	4.72	1.75	0.35	1.22	0.00	0.00	0.17	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	2.45	2.68	0.67	1.78	0.00	0.22	0.22	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	1.28	0.77	0.26	1.02	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	2.85	2.20	0.44	1.10	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	2.32	0.21	0.21	0.84	0.00	0.42	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	2.03	6.10	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	1.36	1.36	1.36	0.68	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	3.11	2.07	0.00	1.04	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	4.80	3.20	0.00	0.53	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	2.14	1.07	1.61	1.07	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	7.02	2.11	2.11	0.70	0.00	0.70	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	3.14	7.06	1.57	1.57	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	1.32	1.32	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	1.64	2.47	0.00	0.82	0.00	0.00	1.64	0.00
CD19+ B Cells, donor2	11624-122B4	3.63	1.45	0.73	2.18	0.00	0.00	2.18	0.00
CD19+ B Cells, donor3	11705-123B4	3.53	1.01	0.00	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	13.74	29.90	8.08	7.27	0.00	1.21	1.62	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	12.78	34.36	12.38	5.59	0.00	0.80	2.00	0.00
CD34+ Progenitors, donor1	11545-120B6	0.00	0.00	4.02	0.00	0.00	1.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	1.69	0.00	2.25	0.00	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	16.53	11.27	18.41	0.75	1.13	0.38	0.00	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	10.37	5.41	13.98	2.71	0.90	0.00	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	22.14	9.64	23.21	1.43	0.00	0.36	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	20.21	11.02	25.11	11.63	0.00	0.61	1.84	0.61
CD4+ T Cells, donor3	11382-118B5	23.48	8.84	33.24	8.54	0.30	0.30	1.22	0.91
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	7.66	5.62	10.98	5.36	0.00	0.00	0.51	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	9.43	2.92	11.45	0.45	0.00	0.45	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	8.91	2.01	15.81	1.72	0.00	0.86	0.29	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	9.96	12.80	25.13	7.11	0.00	0.00	0.95	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	14.75	13.34	25.99	4.21	0.00	0.70	0.70	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	16.48	23.07	16.48	6.59	0.00	0.00	0.00	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	8.53	6.50	9.39	7.23	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	8.81	3.73	8.13	3.90	0.00	0.00	0.17	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	9.51	5.48	8.38	4.03	0.00	1.13	0.32	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	9.86	8.52	21.97	9.41	0.00	0.45	0.90	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	17.82	8.04	25.85	7.34	0.70	0.35	0.35	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	11.88	7.92	18.04	7.92	0.00	0.88	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	8.85	10.12	27.41	9.70	0.00	0.42	0.42	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	15.79	8.31	20.98	7.48	0.21	0.42	0.83	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	16.04	5.68	26.40	9.02	0.00	0.33	1.34	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	15.77	12.51	35.08	6.53	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	16.61	14.47	41.80	8.04	0.54	0.00	0.54	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	25.11	8.97	55.59	5.38	0.00	0.00	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	13.54	6.49	17.43	5.93	0.19	0.93	0.19	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	11.91	6.93	10.61	1.95	0.00	0.65	0.22	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	14.71	8.20	15.97	5.25	0.00	0.63	0.42	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	17.19	7.58	22.75	2.53	0.00	0.51	0.51	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	19.93	15.60	26.00	4.33	0.00	0.87	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	10.90	10.02	24.84	14.38	0.00	0.00	1.74	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	20.29	29.69	36.13	5.44	0.00	0.49	0.49	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	20.31	16.62	31.39	2.77	0.92	0.92	0.92	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	29.31	19.54	23.73	2.79	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	13.29	19.39	33.23	6.65	0.00	0.28	0.55	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	11.29	15.46	31.90	6.63	0.00	0.25	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	10.78	7.70	16.94	4.62	0.00	1.54	1.54	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	23.99	21.13	34.74	8.59	0.00	0.72	0.36	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	26.31	22.16	22.16	6.92	0.00	1.38	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	19.97	9.17	10.80	1.64	0.00	0.65	0.33	0.00
CD8+ T Cells, donor2	11307-117C2	15.02	12.01	15.39	9.39	0.00	0.00	2.63	0.38
CD8+ T Cells, donor3	11383-118B6	24.24	15.40	15.65	3.03	0.25	0.00	1.26	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	3.44	8.49	8.49	7.57	0.00	2.29	0.69	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	3.83	7.67	6.23	4.55	0.00	0.72	0.48	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	1.37	7.39	6.57	4.92	0.00	0.55	1.09	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	1.50	6.00	3.30	5.10	0.30	0.30	2.10	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	2.64	5.76	6.48	2.88	0.24	0.72	1.20	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	2.27	7.28	8.64	5.00	0.23	0.91	0.23	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	1.52	7.39	6.30	4.13	0.00	0.87	1.09	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	3.42	5.53	8.16	5.26	0.26	0.53	1.58	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	3.05	7.97	6.57	5.39	0.00	0.94	1.64	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	3.32	6.94	4.23	4.83	0.00	0.30	0.91	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	4.94	6.68	4.94	4.65	0.00	0.87	2.03	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	4.53	9.59	3.46	5.06	0.00	1.07	0.80	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	2.63	5.25	1.31	0.00	0.00	0.88	0.44	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	2.28	5.01	2.73	3.19	0.00	2.73	0.46	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	0.75	2.24	2.24	0.00	0.00	0.75	0.75	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	3.96	9.72	5.40	3.96	0.00	1.44	1.08	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	5.75	8.92	6.62	2.88	0.29	0.58	0.58	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	4.48	8.25	5.89	3.06	0.00	1.41	0.24	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	2.22	9.19	7.92	4.12	0.32	1.27	2.54	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	4.92	5.54	9.53	4.00	0.00	1.85	1.54	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	3.85	7.69	4.81	2.24	0.32	1.60	0.96	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	3.06	4.21	4.59	0.76	0.00	0.38	1.15	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	1.58	7.49	3.15	3.15	0.00	0.39	1.97	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	4.54	6.81	3.78	3.78	0.00	1.51	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	2.41	11.24	1.61	2.41	0.00	0.80	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	2.10	11.19	4.20	2.10	0.00	0.70	0.70	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	2.00	22.04	7.01	4.01	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	0.00	1.83	7.31	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	5.43	1.98	3.46	2.47	0.00	1.48	0.49	0.49
Cardiac Myocyte, donor3	11686-122I3	15.89	9.05	9.47	1.26	0.95	1.05	0.11	0.21
Chondrocyte - de diff, donor1	11261-116G1	13.17	11.44	42.29	3.12	0.35	4.16	1.04	2.08
Chondrocyte - de diff, donor2	11338-117F6	12.44	4.26	6.04	1.42	0.36	1.78	0.36	1.07
Chondrocyte - de diff, donor3	11410-118E6	19.34	14.91	11.83	5.23	0.91	1.48	1.71	2.84
Chondrocyte - re diff, donor2	11339-117F7	7.16	5.37	5.37	0.00	0.00	0.00	0.00	0.90
Chondrocyte - re diff, donor3	11411-118E7	19.41	8.09	8.90	2.02	0.40	0.81	1.21	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	13.43	4.25	5.28	2.87	0.46	1.26	0.69	0.23
Ciliary Epithelial Cells, donor2	11323-117D9	9.83	4.70	5.34	6.20	0.21	0.64	1.07	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	15.75	3.89	7.26	3.45	0.53	0.80	1.15	0.00
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	15.50	17.88	22.93	1.74	27.05	3.58	1.65	1.19
Corneal Epithelial Cells, donor1	11526-119I5	12.95	19.98	20.86	1.54	0.22	2.63	0.00	0.44
Corneal Epithelial Cells, donor2	11606-120I4	6.83	7.96	6.83	9.10	0.00	1.14	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	13.55	21.47	24.28	3.83	0.77	1.53	1.79	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	2.48	1.16	0.33	0.17	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	3.47	0.63	0.00	0.63	0.00	0.00	0.32	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	3.45	0.00	0.00	0.00	0.00	0.00	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	2.38	0.86	0.11	0.97	0.00	0.00	0.22	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	18.45	3.42	9.91	2.39	0.00	0.00	0.68	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	10.45	1.96	1.31	0.65	0.00	0.00	0.65	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	6.78	2.42	4.36	1.94	0.00	0.00	0.97	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	12.01	4.50	10.01	0.33	0.00	1.33	0.00	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	9.98	2.35	7.63	1.17	0.59	1.76	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	11.31	5.94	11.03	2.26	0.00	0.28	1.70	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	10.62	2.36	16.12	1.18	0.00	1.18	1.18	0.39
Endothelial Cells - Artery, donor1	11264-116G4	10.18	2.91	17.45	4.07	0.00	1.16	1.45	0.29
Endothelial Cells - Artery, donor2	11341-117F9	17.41	3.76	18.59	10.12	0.00	2.35	2.59	0.00
Endothelial Cells - Artery, donor3	11413-118E9	10.87	5.08	11.92	0.88	0.00	2.45	0.53	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	6.21	1.77	5.76	0.44	0.00	0.66	0.00	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	8.82	2.13	6.09	0.30	0.00	0.30	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	6.77	2.54	3.95	0.28	0.00	0.56	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	8.32	4.75	12.78	2.67	0.30	1.78	0.89	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	6.25	2.60	6.77	1.56	0.00	1.04	1.04	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	19.28	4.11	21.55	6.24	0.00	2.84	1.13	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	8.80	6.00	14.40	0.80	0.00	1.60	0.80	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	11.01	4.19	8.39	9.43	0.00	0.52	1.57	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	11.55	6.83	12.05	1.49	0.25	1.62	0.62	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	14.12	4.78	13.90	2.39	0.22	1.74	1.09	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	13.80	5.86	22.11	1.59	0.12	1.10	0.98	0.00
Endothelial Cells - Vein, donor1	11267-116G7	11.38	2.28	22.75	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	8.38	5.59	14.67	1.40	0.00	4.19	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	18.37	4.40	11.30	1.41	0.00	1.26	1.73	0.16
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	6.60	0.00	1.65	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	3.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	12.22	14.17	10.99	1.47	0.00	1.71	0.00	0.73
Esophageal Epithelial Cells, donor2	11587-120G3	4.16	12.48	10.40	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	16.27	16.27	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	13.55	10.67	8.62	2.05	0.41	1.64	0.41	1.23
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	6.35	2.52	3.39	8.98	0.44	1.20	2.74	0.99
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	14.73	10.94	15.28	21.88	0.33	1.63	5.63	1.19
Fibroblast - Aortic Adventitial, donor1	11245-116E3	13.46	10.19	9.46	4.37	0.00	0.97	1.33	0.85
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	9.14	15.01	8.73	1.50	0.55	0.41	0.27	2.73
Fibroblast - Aortic Adventitial, donor2	11326-117E3	18.56	9.18	10.97	10.65	1.37	0.95	0.95	0.95
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	4.48	16.07	11.33	5.27	0.53	1.32	1.05	1.05
Fibroblast - Aortic Adventitial, donor3	11401-118D6	22.92	13.29	15.61	9.97	0.00	0.66	1.33	1.33
Fibroblast - Cardiac, donor1	11268-116G8	21.77	9.07	7.26	2.72	1.36	0.45	3.63	0.91
Fibroblast - Cardiac, donor2	11345-117G4	10.61	6.06	8.34	1.52	1.52	2.27	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	20.19	6.15	7.41	4.26	0.32	0.63	1.10	0.32
Fibroblast - Cardiac, donor4	11452-119A3	15.46	6.37	7.58	0.30	1.82	0.61	0.00	0.91
Fibroblast - Cardiac, donor5	11456-119A7	10.91	5.08	9.14	4.19	0.13	1.02	0.89	0.25
Fibroblast - Cardiac, donor6	11460-119B2	13.64	4.55	10.01	3.94	0.30	1.67	0.91	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	8.58	7.10	7.10	1.07	1.88	1.88	0.13	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	10.35	5.61	5.18	1.29	0.86	3.02	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	20.51	4.39	17.58	0.00	0.00	0.00	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	16.61	25.83	26.29	2.31	1.85	1.85	1.15	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	19.00	12.72	12.38	2.71	3.05	2.04	1.19	0.68
Fibroblast - Dermal, donor1	11269-116G9	8.92	4.93	2.82	1.88	0.23	0.47	0.70	0.70
Fibroblast - Dermal, donor2	11346-117G5	10.38	8.02	13.68	1.89	0.47	3.30	0.47	1.89
Fibroblast - Dermal, donor3	11418-118F5	14.63	6.04	5.08	1.69	0.12	1.09	0.85	0.73
Fibroblast - Dermal, donor4	11450-119A1	7.80	6.67	12.43	5.65	0.23	0.79	0.90	0.00
Fibroblast - Dermal, donor5	11454-119A5	8.02	6.11	10.99	3.49	0.17	0.00	1.05	0.17
Fibroblast - Dermal, donor6	11458-119A9	10.88	5.85	13.48	3.90	0.65	0.49	1.79	0.00
Fibroblast - Gingival, donor1	11237-116D4	10.20	9.79	9.37	1.67	0.42	1.04	0.42	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	14.93	11.27	15.46	9.43	0.26	1.83	0.52	0.79
Fibroblast - Gingival, donor2	11318-117D4	14.89	11.47	15.02	7.91	0.53	2.11	2.64	0.26
Fibroblast - Gingival, donor3	11394-118C8	15.86	18.76	9.77	2.90	0.48	1.06	0.58	1.45
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	20.78	17.66	6.23	4.16	0.00	3.12	0.00	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	12.51	10.92	9.69	11.10	0.35	0.88	1.06	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	13.56	16.68	28.53	5.30	0.47	0.62	1.71	2.03
Fibroblast - Gingival, donor6 (control)	11922-125H5	10.28	12.17	19.47	5.54	0.00	1.35	0.95	1.49
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	32.46	26.82	45.17	4.59	0.35	2.12	0.35	1.41
Fibroblast - Gingival, donor7 (control)	11924-125H7	10.68	11.11	14.04	5.85	0.15	1.46	0.44	0.58
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	8.18	8.18	16.36	6.14	0.41	2.05	0.95	1.23
Fibroblast - Gingival, donor8 (control)	11926-125H9	8.99	9.32	24.35	7.02	0.33	1.65	0.88	0.22
Fibroblast - Gingival, donor9 (control)	11927-125I1	13.35	12.77	10.57	7.34	1.03	1.03	1.47	0.15
Fibroblast - Lung, donor1	11270-116H1	16.31	4.08	6.80	1.36	0.00	2.72	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	14.92	5.97	11.94	1.49	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	27.65	11.61	14.14	7.81	0.21	1.06	3.80	0.84
Fibroblast - Lymphatic, donor1	11506-119G3	8.33	11.66	18.33	0.83	1.67	4.17	0.00	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	5.59	12.59	9.79	0.00	1.40	2.80	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	7.84	10.08	6.16	2.80	0.28	1.40	1.96	0.56
Fibroblast - Mammary, donor1	11540-120B1	19.08	9.74	16.64	1.22	0.81	1.62	0.81	0.41
Fibroblast - Mammary, donor2	11620-122A9	35.95	11.98	39.94	11.98	0.00	0.00	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	17.87	0.00	0.00	5.96	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	9.31	7.76	9.89	0.97	0.19	1.36	0.58	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	14.86	8.04	12.29	6.83	0.61	1.52	0.61	0.30
Fibroblast - Periodontal Ligament, donor3	11395-118C9	7.96	8.87	10.71	0.61	0.31	1.84	0.31	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	15.65	10.69	16.03	7.25	0.76	0.76	0.38	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	12.15	11.07	9.18	7.02	0.00	0.27	1.08	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	13.92	8.70	6.49	4.41	0.23	0.70	0.23	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	15.70	5.75	10.83	1.77	0.11	1.44	0.88	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	14.83	11.38	18.08	0.61	1.83	2.24	0.81	0.81
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	14.70	12.03	20.71	8.02	0.00	0.00	2.00	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	18.58	10.67	15.42	5.14	1.58	1.58	2.77	1.19
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	2.98	10.52	5.75	2.78	0.20	0.79	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	15.63	6.75	5.15	3.37	0.18	0.89	0.53	0.53
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	15.77	9.66	12.02	1.97	1.18	1.18	0.79	0.99
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	3.01	9.03	7.52	1.50	0.00	0.60	0.00	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	11.44	10.80	7.45	5.29	0.97	0.76	0.54	1.08
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	5.57	12.91	5.82	2.02	0.76	0.51	0.51	0.76
Fibroblast - skin normal, donor1	11553-120C5	13.62	9.19	6.40	3.61	0.49	1.31	0.33	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	9.02	12.23	10.83	0.80	0.00	1.20	0.20	0.40
Fibroblast - skin normal, donor2	11561-120D4	7.74	11.25	12.16	5.02	0.70	1.31	0.50	0.80
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	6.04	13.00	5.44	1.51	0.00	0.00	0.91	1.21
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	13.59	9.78	5.47	3.81	0.99	0.99	0.41	1.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	9.74	11.11	8.55	6.33	0.34	3.42	0.85	2.05
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	3.94	6.57	4.27	0.99	0.33	0.33	0.00	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	7.24	9.05	4.47	5.11	0.11	0.53	0.64	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	14.51	8.27	9.28	2.53	1.01	1.35	0.51	0.67
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	7.21	8.31	6.12	25.56	0.63	0.47	8.00	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	44.32	44.32	0.00	44.32	0.00	0.00	22.16	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	13.94	6.10	5.23	2.61	0.00	0.00	0.00	1.74
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	8.15	3.29	2.08	0.87	0.00	0.69	0.00	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	9.37	3.64	4.16	0.00	0.26	0.52	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	9.96	4.34	4.09	1.02	0.26	0.26	0.00	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	6.12	0.77	3.83	1.53	0.00	2.30	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	3.83	4.47	3.19	3.19	0.00	0.64	0.64	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	5.42	5.42	2.00	5.42	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	11.86	15.99	15.44	6.07	0.00	1.38	0.55	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	13.70	19.86	19.64	7.31	0.23	1.60	0.00	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	9.51	5.94	4.76	6.34	0.20	0.40	0.40	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	12.16	12.16	9.78	8.19	0.26	0.79	0.53	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	19.24	23.16	27.40	8.48	0.33	3.26	0.65	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	4.42	2.21	0.44	2.65	0.00	0.44	1.33	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	5.37	8.06	3.53	2.83	0.28	0.42	0.28	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	6.65	5.42	5.30	2.96	0.00	0.99	0.37	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	6.72	4.84	2.69	2.42	0.00	0.81	0.27	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	7.06	4.21	5.82	2.60	0.00	1.86	0.50	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	6.23	5.26	5.26	1.52	0.00	0.97	1.25	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	3.46	4.27	3.25	3.05	0.81	1.42	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	7.07	4.34	3.88	2.97	0.00	0.91	0.91	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	6.35	3.99	7.22	2.74	0.12	0.75	0.75	0.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	5.46	4.59	8.52	1.53	0.00	0.66	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	9.46	2.95	3.55	3.84	0.00	0.89	0.30	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	8.74	7.31	7.79	3.34	0.32	0.32	1.11	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	6.48	4.02	5.36	2.01	0.00	0.45	0.45	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	8.67	5.65	3.63	4.64	0.20	1.41	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	10.52	5.09	4.58	2.88	0.17	0.85	0.51	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	6.74	4.61	4.08	0.98	0.53	1.33	0.18	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	8.84	3.64	3.33	0.62	0.10	0.94	0.10	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	5.81	1.54	2.05	1.02	0.00	0.51	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	9.52	4.32	3.76	2.77	0.00	0.33	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	6.07	3.58	4.08	0.75	0.50	0.67	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	5.92	3.27	2.86	1.02	0.82	1.02	0.41	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	8.87	3.71	3.30	2.48	0.00	0.41	0.83	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	8.99	4.73	3.80	2.54	0.12	0.46	1.04	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	8.51	5.00	3.50	3.67	0.17	1.00	0.83	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	6.61	2.42	1.98	3.53	0.00	1.10	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	7.75	4.18	2.95	1.60	0.12	0.61	1.11	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	8.92	3.89	3.08	1.78	0.16	0.16	0.16	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	5.77	2.89	2.57	1.92	0.00	0.32	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	7.68	3.51	2.65	1.33	0.09	0.38	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	10.28	2.53	3.64	2.85	0.32	0.00	0.47	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	7.60	1.22	1.82	1.82	0.00	0.00	1.22	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	7.42	2.82	2.51	1.46	0.00	0.42	0.42	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	6.59	3.51	3.51	1.54	0.22	0.22	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	6.73	3.09	2.24	1.68	0.00	0.28	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	7.04	1.85	2.50	1.20	0.09	0.19	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	6.69	3.74	2.94	2.67	0.27	0.27	0.53	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	7.65	2.30	3.83	3.37	0.00	0.46	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	8.29	3.11	2.33	1.81	0.00	0.13	0.52	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	9.22	1.90	1.08	1.63	0.00	0.27	0.54	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	7.74	2.77	3.32	4.61	0.00	0.18	1.84	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	7.02	2.19	5.26	4.82	0.00	0.22	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	9.92	8.93	7.93	0.99	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	10.68	4.49	5.28	4.22	0.40	0.53	0.13	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	13.52	4.44	3.83	4.64	0.20	0.61	1.61	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	13.22	7.12	5.59	0.76	0.25	2.29	0.00	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	2.59	4.38	1.79	0.40	0.20	1.19	0.00	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	5.85	8.17	2.93	2.31	0.00	0.77	0.31	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	4.91	9.21	1.23	0.82	0.00	0.82	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	10.01	5.01	4.38	0.00	0.31	1.56	0.63	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	2.83	5.65	2.83	0.85	0.00	1.41	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	2.77	5.07	2.77	2.31	0.00	1.38	0.92	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	4.95	0.00	7.42	2.47	0.00	4.95	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	6.58	6.58	5.80	3.48	0.39	1.16	2.71	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	4.81	3.21	0.00	6.42	1.60	3.21	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	10.43	6.96	1.74	0.00	0.00	1.74	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	8.46	5.53	2.28	3.58	0.65	0.98	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	1.65	7.41	5.77	4.94	0.00	1.24	2.47	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	19.99	6.66	3.33	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	6.71	4.47	5.31	3.36	0.28	1.12	1.40	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	3.60	6.21	5.88	4.58	0.65	1.63	1.63	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	15.10	3.36	3.36	2.52	1.68	1.68	2.52	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	4.77	5.73	8.27	4.77	0.32	0.64	0.95	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	7.47	4.42	4.76	2.04	0.68	1.02	2.04	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	4.18	2.09	2.09	2.09	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	7.45	7.45	9.74	6.87	0.57	1.15	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	7.40	8.29	7.99	2.96	0.59	0.89	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	11.86	5.08	8.47	1.69	1.69	1.69	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	6.63	5.80	12.01	8.70	1.24	1.24	2.49	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	4.83	4.37	8.28	2.30	0.46	0.69	0.69	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	10.54	5.27	15.81	0.00	0.00	5.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	4.61	4.61	7.69	5.77	1.15	1.92	1.92	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	8.80	9.13	12.71	6.52	1.63	0.98	1.96	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	13.38	5.35	10.70	5.35	0.67	2.01	1.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	6.93	11.17	12.71	12.33	1.16	0.77	2.31	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	7.19	5.14	13.69	4.79	1.03	2.40	1.37	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	14.91	7.45	17.39	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	8.97	8.97	11.32	3.77	0.00	1.89	0.94	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	3.02	10.26	15.69	12.67	1.21	0.60	3.02	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	12.72	9.16	19.33	5.60	3.56	1.02	3.56	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	11.57	7.18	7.98	4.39	2.79	1.60	0.40	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	7.89	9.87	11.84	8.39	3.45	0.00	2.47	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	5.90	3.54	17.71	4.72	1.18	0.00	1.18	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	8.75	9.92	11.67	3.50	1.17	1.17	2.33	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	7.02	12.73	9.22	4.39	0.88	1.32	0.44	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	3.39	5.93	4.24	3.39	0.85	0.00	1.70	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	8.95	2.39	9.55	4.78	0.60	1.19	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	13.10	6.79	10.68	9.22	3.88	0.49	1.94	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	14.84	7.99	5.71	1.14	1.14	0.00	4.57	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	17.05	8.73	5.82	13.31	0.83	1.25	2.08	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	30.36	22.49	14.62	0.00	0.00	1.12	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	6.66	3.49	1.27	2.54	0.00	0.63	0.32	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	6.68	5.43	4.60	3.76	0.00	0.00	0.84	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	13.46	11.49	12.18	6.73	4.06	0.93	1.97	2.09
Hep-2 cells mock treated, biol_rep2	11899-125E9	8.95	15.53	10.97	9.45	2.70	2.03	1.86	2.19
Hep-2 cells mock treated, biol_rep3	11900-125F1	9.33	11.15	10.01	6.60	2.50	1.14	1.14	1.14
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	11.81	13.44	11.48	9.95	2.19	1.31	2.08	2.19
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	9.67	13.75	12.04	6.23	3.87	1.50	0.86	3.44
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	10.12	9.90	10.12	6.46	1.72	1.29	0.43	1.29
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	12.83	10.59	9.46	7.60	3.61	2.12	1.62	3.11
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	9.78	9.78	9.95	7.21	3.09	2.06	1.37	1.72
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	10.25	14.42	11.53	6.73	3.84	0.96	0.96	1.28
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	11.19	3.92	14.55	3.92	0.00	1.68	1.12	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	9.95	6.49	9.52	2.60	0.43	1.30	0.87	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	7.93	5.29	5.29	13.22	0.00	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	16.23	9.17	20.46	1.06	1.06	1.06	0.35	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	19.62	15.98	18.16	3.63	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	12.59	9.44	20.98	5.42	0.87	1.40	2.27	0.00
Hepatocyte, donor1	11523-119I2	10.90	12.11	13.32	8.47	25.42	6.05	3.63	3.63
Hepatocyte, donor2	11603-120I1	8.62	0.00	1.08	1.08	4.31	3.23	3.23	0.00
Hepatocyte, donor3	11684-122I1	6.14	6.75	1.84	4.29	4.29	0.61	0.61	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	2.61	0.00	0.00	2.61	0.00	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	16.60	22.37	10.84	4.54	14.33	3.32	1.05	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	7.96	3.43	4.53	0.96	0.55	0.69	0.14	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	6.37	19.10	38.21	9.55	0.00	9.55	3.18	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	26.70	13.35	20.03	0.00	0.00	13.35	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	108.33	27.08	27.08	0.00	0.00	54.17	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	11.08	18.00	22.15	4.15	1.38	4.15	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	10.01	27.53	7.51	5.01	0.00	0.00	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	11.87	23.74	23.74	0.00	11.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	15.38	28.19	23.07	12.81	0.00	2.56	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	4.57	36.57	4.57	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	16.24	37.36	9.75	16.24	0.00	0.00	3.25	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	10.00	30.01	15.01	6.67	0.00	3.33	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	0.00	21.78	3.63	18.15	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	10.59	22.50	18.53	5.29	0.00	3.97	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	3.33	15.52	8.87	5.54	0.00	3.33	1.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	0.00	26.19	5.24	26.19	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	13.86	24.56	17.64	7.56	0.63	0.63	2.52	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	12.37	21.65	13.92	7.73	0.00	1.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	29.27	14.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	15.50	21.32	18.09	5.17	0.00	1.29	0.65	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	11.27	25.76	17.71	11.27	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	23.90	11.95	11.95	0.00	23.90	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	8.15	26.89	27.71	7.33	0.00	3.26	0.81	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	13.43	22.25	18.05	3.78	0.00	2.10	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	14.37	14.37	0.00	14.37	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	10.45	28.93	20.09	6.43	0.00	0.80	2.41	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	6.46	16.62	15.70	9.23	0.00	0.92	0.92	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	0.00	30.16	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	8.50	21.71	15.11	7.55	0.00	0.47	0.94	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	11.79	19.95	15.42	9.98	0.00	0.91	1.81	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	29.48	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	17.22	26.90	20.45	3.23	0.00	0.00	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	12.70	15.25	19.06	8.89	0.00	2.54	1.27	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	32.86	16.43	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	14.03	30.61	23.59	7.01	0.64	1.28	1.28	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	5.47	7.29	20.05	9.11	0.00	0.00	0.00	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	15.80	31.61	15.80	0.00	15.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	10.00	30.70	19.99	3.57	0.00	0.71	1.43	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	16.59	6.64	23.23	9.95	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	41.70	41.70	20.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	12.04	14.51	10.80	2.47	0.62	1.23	1.85	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	5.27	24.58	12.29	3.51	0.00	1.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	25.15	18.86	18.86	3.14	0.00	3.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	9.04	31.29	9.04	6.26	0.00	2.09	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	13.28	35.41	13.28	2.21	0.00	4.43	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	9.73	22.69	19.45	16.21	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	6.98	43.60	15.69	3.49	0.00	0.87	0.87	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	6.75	53.99	9.00	4.50	0.00	2.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	6.97	24.39	3.48	17.42	0.00	6.97	3.48	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	16.00	60.81	13.87	6.40	0.00	0.00	3.20	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	8.31	29.09	22.17	6.93	0.00	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	8.55	37.04	17.10	2.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	10.12	33.14	26.69	2.76	0.00	0.92	0.92	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	15.13	24.20	18.15	0.00	0.00	3.03	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	55.88	6.21	6.21	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	23.26	46.52	7.40	5.29	0.00	1.06	2.11	1.06
Keratinocyte - epidermal, donor1	11272-116H3	7.67	7.26	4.98	3.35	0.41	1.31	0.16	0.49
Keratinocyte - epidermal, donor2	11349-117G8	7.61	16.40	5.27	0.59	0.59	1.76	1.17	1.76
Keratinocyte - epidermal, donor3	11421-118F8	13.16	11.83	6.34	2.65	0.19	0.95	1.42	0.47
Keratinocyte - oral, donor1	11251-116E9	15.55	20.32	20.89	3.52	0.45	1.93	1.14	0.57
Keratocytes, donor1	11527-119I6	12.03	17.19	12.38	1.72	1.72	0.00	0.00	0.69
Keratocytes, donor2	11607-120I5	10.55	11.72	24.61	1.17	2.34	2.34	1.17	4.69
Keratocytes, donor3	11688-122I5	6.52	7.90	8.69	3.75	1.38	1.98	0.79	0.79
Krukenberg tumor cell line:HSKTC	10687-109F3	10.99	2.20	10.99	2.20	0.00	4.40	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	3.24	5.39	7.55	3.24	0.00	1.08	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	11.76	7.15	3.34	0.46	0.00	0.69	0.12	0.12
Lens Epithelial Cells, donor3	11690-122I7	6.36	4.24	3.33	0.10	0.30	0.20	0.30	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	10.20	5.57	13.99	2.13	0.36	1.42	1.42	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	8.93	6.70	20.37	2.51	0.28	0.84	2.51	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	8.03	3.62	8.82	2.05	0.47	0.47	1.26	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	2.15	3.76	13.98	9.68	0.54	0.54	1.61	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	8.19	3.78	17.96	0.63	0.00	1.26	0.63	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	9.38	4.31	14.77	2.70	0.22	0.86	1.51	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	2.87	1.64	8.21	2.46	0.00	0.41	2.05	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	8.85	6.57	23.26	3.54	0.25	0.76	1.52	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	7.74	4.79	14.50	1.55	0.28	1.55	2.11	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	10.28	4.75	11.87	4.35	0.00	1.98	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	9.89	3.10	12.99	1.74	0.58	1.74	1.16	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	10.18	5.74	13.15	1.48	0.37	1.30	2.78	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	10.80	4.88	13.24	5.92	0.35	1.05	1.74	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	8.11	5.96	20.51	1.43	0.00	2.39	1.43	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	7.00	7.28	15.25	4.40	0.14	0.96	2.06	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	9.55	2.46	9.24	4.00	0.00	1.85	2.16	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	7.79	6.86	16.21	2.18	0.62	2.49	2.18	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	8.78	5.67	16.65	2.01	0.18	1.28	2.01	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	5.59	4.94	9.54	3.95	0.33	0.66	1.65	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	7.61	7.03	19.33	4.98	0.29	0.59	1.46	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	9.71	4.48	17.43	4.48	0.25	1.99	2.99	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	6.30	4.36	11.15	4.36	0.00	0.48	4.36	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	6.19	5.66	15.89	1.62	0.27	1.08	1.08	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	7.57	3.78	13.02	4.09	0.15	2.42	2.12	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	7.26	5.18	12.44	2.59	0.00	0.52	1.04	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	7.96	5.03	14.24	0.42	0.42	1.26	1.68	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	7.97	5.11	14.89	2.86	0.00	1.50	1.20	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	4.13	4.13	11.01	4.13	0.00	1.38	3.44	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	10.54	4.89	17.50	2.63	0.19	0.75	2.07	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	9.86	4.24	18.13	3.29	0.32	1.06	2.76	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	4.85	2.91	11.15	1.94	0.00	0.97	1.94	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	7.61	3.64	16.54	3.31	0.33	0.99	1.98	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	9.91	3.96	18.21	4.58	0.50	0.87	2.48	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	3.70	3.70	10.37	2.22	0.00	2.22	1.11	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	6.18	4.20	14.82	1.48	0.00	0.99	0.99	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	8.80	5.64	16.09	3.57	0.41	1.65	2.61	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	6.75	3.22	13.83	2.89	0.00	1.29	1.61	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	6.39	4.26	18.26	0.91	0.61	1.22	1.52	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	7.00	3.50	14.70	2.52	0.42	1.54	1.68	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	6.04	4.27	16.36	3.20	0.00	1.78	1.07	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	5.33	5.33	17.94	1.45	0.97	0.97	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	11.98	6.38	18.36	2.65	0.31	1.24	0.78	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	7.88	5.73	13.97	3.58	0.72	1.43	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	8.82	4.25	23.85	2.61	0.00	1.31	1.96	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	9.42	3.06	17.66	2.35	0.00	2.59	1.88	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	12.87	5.32	13.49	1.98	0.25	1.86	1.61	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	12.29	7.17	21.51	2.05	0.00	1.28	1.02	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	8.06	2.69	13.13	3.88	0.00	2.69	2.09	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	45.32	29.46	43.05	9.06	0.00	4.53	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	58.30	39.12	53.70	35.29	0.00	11.51	2.30	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	42.31	30.43	57.89	12.62	0.74	5.94	5.94	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	24.12	30.47	41.04	47.39	0.85	5.92	6.35	1.27
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	64.71	44.31	47.83	21.10	1.41	8.44	3.52	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	38.29	29.89	42.96	26.15	0.00	4.67	9.34	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	22.67	29.37	37.10	73.68	0.52	4.12	5.15	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	51.15	40.44	45.20	30.93	0.00	8.33	7.14	2.38
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	47.27	45.92	45.01	10.86	1.13	8.82	2.71	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	18.61	22.68	36.94	52.06	0.00	4.07	5.82	0.87
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	36.01	37.36	36.91	32.86	0.00	4.95	4.05	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	53.79	50.13	58.53	19.51	0.54	10.30	1.90	1.08
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	24.14	30.81	51.35	47.24	1.54	7.70	6.16	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	51.87	36.34	45.17	24.70	0.35	4.94	2.47	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	27.98	26.65	35.98	14.66	0.00	5.33	1.33	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	33.11	33.11	51.96	49.92	0.51	4.58	6.11	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	51.49	36.82	49.36	29.35	0.80	6.14	3.20	0.80
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	38.54	33.44	47.43	44.59	0.00	4.91	5.10	0.57
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	20.86	36.81	46.63	47.24	0.00	5.52	2.45	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	49.74	48.11	49.74	34.25	0.00	8.97	3.26	2.45
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	32.69	32.90	42.27	36.65	0.00	4.37	4.79	0.83
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	24.38	23.26	37.27	35.03	0.56	4.76	5.32	0.84
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	50.49	36.06	61.82	16.49	0.00	11.33	5.15	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	37.16	29.32	51.96	49.35	0.87	2.61	7.26	1.16
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	22.12	28.70	40.06	34.97	0.60	5.08	5.08	1.49
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	48.69	28.22	45.37	22.68	0.00	8.85	1.66	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	38.88	43.83	60.09	43.13	0.00	4.60	5.66	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	25.08	24.71	47.57	43.52	0.74	8.11	2.21	1.48
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	31.08	35.69	54.11	41.45	1.15	6.91	4.61	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	53.34	44.90	53.34	42.21	0.77	5.76	9.21	0.77
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	20.95	23.21	53.78	65.11	0.00	5.66	3.96	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	50.05	38.56	55.79	29.54	0.00	6.56	3.28	2.46
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	34.34	37.96	60.10	50.61	0.00	8.59	4.07	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	22.98	20.11	57.45	44.52	0.00	6.46	2.87	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	53.03	38.84	62.74	21.66	0.00	5.23	2.99	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	36.04	30.84	50.91	56.48	0.37	6.32	5.20	1.11
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	23.26	20.25	40.06	37.91	0.43	5.60	5.17	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	37.68	39.39	47.95	27.40	0.86	2.57	1.71	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	39.98	47.64	53.31	60.31	0.33	8.00	5.33	2.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	30.17	22.93	46.45	32.58	0.60	8.45	3.62	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	62.57	42.66	54.04	24.17	0.00	7.82	4.27	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	46.40	35.06	56.71	37.47	0.34	9.28	5.16	1.03
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	22.54	24.69	47.23	37.04	0.00	6.44	5.37	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	49.16	39.05	55.22	26.26	0.00	11.45	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	30.74	40.00	50.01	47.78	0.00	5.93	8.52	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	18.61	29.07	39.54	5.81	0.00	9.30	0.00	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	47.60	44.43	46.54	16.92	0.00	6.35	5.29	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	38.81	41.22	42.02	38.81	0.40	7.20	6.40	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	19.63	33.44	35.62	31.98	0.00	2.91	2.91	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	62.09	52.89	55.19	41.39	0.77	9.96	5.37	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	49.33	40.45	55.74	57.71	0.00	7.89	3.45	1.48
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	17.88	32.93	39.52	36.70	0.00	7.53	2.82	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	53.80	51.79	63.36	31.68	0.00	8.05	4.53	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	41.46	41.46	59.03	53.17	0.45	7.21	2.70	1.35
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	8.61	25.82	49.91	56.80	0.00	10.33	5.16	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	53.44	49.88	53.89	26.28	0.00	12.47	5.34	0.89
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	41.84	42.62	57.09	49.66	0.00	8.21	6.65	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	29.69	19.79	51.46	39.58	0.00	5.28	7.26	1.32
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	60.71	55.01	52.93	31.65	0.00	9.34	7.78	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	40.69	45.94	50.32	53.38	0.44	5.25	5.69	1.31
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	20.69	34.11	40.81	39.70	0.00	5.03	1.68	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	57.86	45.93	56.53	25.17	0.44	9.27	3.09	2.21
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	36.26	44.74	51.30	43.20	1.16	8.10	7.33	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	22.79	26.84	45.07	44.05	0.51	7.09	6.58	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	45.18	51.91	54.79	23.55	0.00	7.21	6.25	1.92
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	35.78	35.78	57.25	42.14	0.80	6.76	6.76	1.19
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	20.05	27.95	46.18	34.03	1.22	3.65	5.47	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	16.60	43.58	43.58	17.29	0.69	8.30	1.38	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	40.66	38.38	53.96	40.28	0.38	4.94	4.56	1.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	24.27	21.17	48.03	46.48	0.00	10.33	5.16	1.55
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	26.60	41.12	52.60	21.16	1.81	7.26	3.02	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	38.03	41.20	59.89	42.46	0.00	6.65	5.07	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	20.26	38.92	55.97	36.25	0.53	7.46	2.13	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	19.54	41.95	50.00	27.58	1.15	5.75	2.87	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	42.17	41.65	65.82	36.51	0.00	7.20	5.14	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	19.10	26.88	55.88	38.90	0.71	7.78	2.12	2.12
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	26.67	41.99	52.21	26.67	0.57	5.11	1.70	2.27
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	40.35	44.10	65.32	53.25	0.42	9.57	5.41	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	18.01	28.97	51.68	50.11	2.35	7.05	7.05	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	25.47	42.59	58.87	26.72	1.25	9.19	3.76	0.84
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	45.53	34.85	72.02	46.00	0.93	8.36	5.58	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	22.75	37.47	68.24	44.83	1.34	5.35	5.35	3.35
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	31.01	53.46	76.99	28.87	1.60	7.48	4.28	2.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	42.83	48.90	56.98	57.79	0.81	5.25	7.27	0.81
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	23.86	41.30	59.65	33.96	0.92	10.10	5.51	1.84
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	18.67	57.79	66.68	44.46	0.89	9.78	1.78	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	49.01	59.84	92.32	50.72	1.71	10.83	6.27	2.85
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	21.47	39.11	81.29	51.38	0.00	9.20	3.83	3.83
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	18.06	38.85	67.85	35.02	0.55	12.04	1.09	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	49.44	63.25	80.18	53.45	0.89	8.46	6.24	2.23
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	50.43	67.85	85.27	17.94	1.82	10.66	2.08	3.38
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	31.83	70.95	92.83	31.17	0.00	8.62	1.99	3.98
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	43.65	66.52	126.80	60.28	0.00	8.31	10.39	4.16
Macrophage - monocyte derived, donor1	11232-116C8	3.65	0.91	0.46	0.23	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	1.84	0.18	0.37	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	6.16	1.44	0.92	0.79	0.13	0.00	0.26	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	6.90	2.12	1.59	0.53	0.00	1.06	0.00	0.53
Mallassez-derived cells, donor2	11929-125I3	6.02	5.70	2.85	5.86	0.00	0.32	0.63	0.00
Mallassez-derived cells, donor3	11930-125I4	4.73	2.64	4.45	3.89	0.56	0.69	0.83	0.69
Mammary Epithelial Cell, donor1	11273-116H4	11.66	27.40	32.78	1.69	0.30	3.09	1.10	1.40
Mammary Epithelial Cell, donor2	11350-117G9	10.42	17.66	21.72	7.24	0.87	0.58	0.87	1.16
Mammary Epithelial Cell, donor3	11422-118F9	23.94	16.46	19.70	1.00	0.25	1.50	0.75	1.50
Mast cell - stimulated, donor1	11487-119E2	0.68	2.03	0.68	0.00	0.00	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	6.70	6.06	5.52	1.62	0.11	0.32	0.00	0.00
Mast cell, donor2	11565-120D8	17.24	5.94	4.75	1.78	0.00	0.00	0.00	0.30
Mast cell, donor3	11566-120D9	16.21	11.93	6.98	4.73	0.23	0.45	0.00	1.13
Mast cell, donor4	11567-120E1	21.45	13.47	6.56	2.48	0.00	1.24	0.00	0.18
Mast cell, expanded and stimulated, donor5	11940-126A5	0.67	3.11	0.33	0.78	0.00	0.00	0.11	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	1.17	0.00	1.17	2.33	0.00	0.00	0.58	0.58
Mast cell, expanded, donor5	11939-126A4	5.16	5.28	3.56	2.18	0.00	0.00	0.11	0.23
Mast cell, expanded, donor8	11941-126A6	5.36	1.84	2.68	4.35	0.17	0.00	0.33	0.00
Melanocyte - dark, donor1	11502-119F8	13.83	2.79	7.56	1.59	0.10	1.19	0.40	0.10
Melanocyte - dark, donor2	11582-120F7	7.27	4.15	6.92	1.73	1.04	0.69	0.00	0.69
Melanocyte - dark, donor3	11663-122F7	11.66	3.19	1.09	0.36	0.00	0.51	0.14	0.00
Melanocyte - light, donor1	11274-116H5	4.47	1.65	0.24	0.47	0.00	0.47	0.24	0.00
Melanocyte - light, donor2	11351-117H1	8.19	2.05	0.00	0.00	0.00	0.68	0.68	0.00
Melanocyte - light, donor3	11423-118G1	12.14	2.60	5.20	1.73	0.00	0.00	0.87	1.73
Melanocyte, donor1 (MC+1)	12641-134G4	12.81	2.08	0.73	3.02	0.00	0.83	0.52	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	6.45	1.34	1.88	4.30	0.00	0.00	0.54	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	6.43	2.14	1.07	1.34	0.00	0.27	0.80	0.00
Meningeal Cells, donor1	11493-119E8	13.40	6.45	15.26	1.12	1.12	1.86	0.37	0.12
Meningeal Cells, donor2	11573-120E7	11.88	6.16	10.12	3.96	0.44	0.88	1.32	0.00
Meningeal Cells, donor3	11654-122E7	9.86	7.34	14.02	3.83	0.73	2.45	0.57	0.24
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	16.82	7.98	14.26	1.43	0.29	1.43	0.29	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	5.74	2.11	2.11	0.70	0.10	0.81	0.00	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	59.14	26.28	32.85	3.94	1.31	13.14	0.00	5.26
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	15.70	7.85	13.08	1.31	0.00	1.31	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	10.05	7.18	9.33	2.87	0.72	2.15	2.15	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	8.89	5.72	5.51	3.39	0.42	1.48	0.21	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	6.03	4.52	9.05	3.02	0.00	1.01	2.01	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	16.26	10.11	29.67	1.76	0.66	3.30	0.22	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	16.80	12.42	45.30	1.46	0.73	2.19	2.19	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	13.71	14.32	34.58	4.50	0.82	4.30	1.02	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	7.76	9.00	9.56	0.69	2.08	5.68	0.14	0.42
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	13.01	7.81	11.52	1.86	0.37	4.46	0.74	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	8.55	9.08	7.24	2.37	0.79	1.18	0.79	0.39
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	7.42	16.91	8.61	2.37	1.78	2.08	0.00	1.48
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	7.01	7.01	23.36	9.34	0.00	4.67	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	14.09	11.53	26.90	3.20	3.20	0.00	0.64	2.56
Mesenchymal stem cells - adipose, donor0	11217-116B2	14.18	6.03	6.38	0.71	0.00	1.42	0.35	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	9.38	9.69	10.32	1.25	0.31	1.56	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	15.24	10.89	26.12	4.35	2.18	1.45	1.45	0.73
Mesothelial Cells, donor1	11247-116E5	12.99	1.86	1.59	1.59	0.00	0.53	0.27	0.00
Mesothelial Cells, donor2	12156-128G5	8.01	2.50	2.00	0.00	0.00	0.50	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	10.98	2.96	1.52	1.52	0.07	0.51	0.07	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	1.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	2.46	0.25	0.00	0.99	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	1.77	0.00	0.29	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	1.24	1.24	0.93	0.31	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	2.07	0.62	0.21	0.00	0.00	0.00	0.00	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	2.00	0.00	0.00	0.50	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	1.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	1.83	0.41	0.20	0.61	0.00	0.00	0.20	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	0.79	0.40	0.40	0.40	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	0.88	2.65	0.00	0.88	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	2.66	0.76	0.38	0.38	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	1.49	0.64	0.21	0.64	0.00	0.00	0.21	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	0.30	0.00	0.30	0.60	0.00	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	5.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	2.01	0.50	0.25	0.00	0.00	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	0.71	0.48	0.71	0.24	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	1.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	0.69	0.69	0.23	0.69	0.00	0.23	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	1.05	0.00	0.21	0.42	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	1.02	0.20	0.00	0.41	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	1.72	0.21	0.00	0.43	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	0.89	0.44	0.00	0.22	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	0.66	0.44	0.00	0.66	0.00	0.00	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	1.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	0.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	0.59	0.59	0.00	0.29	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	1.92	0.00	0.00	0.48	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	1.20	0.40	0.00	0.80	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	1.00	0.00	0.50	0.50	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	2.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	0.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	0.74	0.00	0.25	0.50	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	1.71	0.00	0.00	1.37	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	0.00	0.36	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	0.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	1.21	0.30	0.00	0.60	0.00	0.00	0.30	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	0.00	0.00	0.83	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	0.00	0.00	0.00	0.92	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	0.00	0.57	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	0.55	0.55	0.28	0.28	0.00	0.00	0.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	0.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	0.43	0.43	0.43	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	0.00	0.64	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	0.27	0.53	0.00	0.27	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	0.60	1.20	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	0.71	0.28	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	0.32	0.64	0.00	0.64	0.00	0.00	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	0.44	0.22	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	1.52	0.76	0.00	0.38	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	0.57	1.42	0.28	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	0.74	1.47	0.25	0.49	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	1.30	0.65	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	0.00	0.29	0.59	0.29	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	0.58	0.86	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	1.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	0.60	0.89	0.00	0.30	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	3.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	1.78	0.00	0.00	1.78	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	3.94	0.99	0.33	1.64	0.00	0.00	0.33	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	4.21	0.00	0.00	2.10	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	4.35	0.99	0.79	0.79	0.00	0.20	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	1.86	0.93	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	4.13	1.50	0.38	1.13	0.00	0.38	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	2.93	0.27	0.27	0.27	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	1.81	0.90	0.23	0.45	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	2.95	0.74	0.00	0.00	0.00	0.00	0.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	4.03	0.37	0.37	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	1.56	0.00	0.00	0.00	0.00	0.00	0.00	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	0.00	0.53	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	2.02	1.01	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	0.42	0.42	0.84	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	0.00	0.00	2.72	1.36	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.00	0.64	0.64	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	0.00	3.02	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	0.00	3.26	6.52	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	0.00	0.00	4.75	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	9.48	4.96	2.37	1.51	0.22	0.43	0.43	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	10.97	7.32	9.41	1.05	0.00	0.52	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	19.36	3.34	6.67	4.67	0.67	2.00	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	22.54	2.92	19.20	2.09	0.00	0.83	0.00	1.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	10.65	4.94	7.23	20.16	0.38	0.57	3.99	0.57
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	7.98	7.98	17.55	1.60	0.00	1.60	0.00	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	14.96	2.72	7.48	2.04	0.00	1.36	1.36	1.36
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	7.35	11.03	5.51	16.54	0.00	1.84	3.68	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	17.16	2.51	5.86	4.60	0.42	2.09	0.42	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	18.13	2.56	11.85	4.88	0.46	2.32	2.09	1.63
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	18.65	3.51	6.76	2.16	0.00	1.89	0.54	1.08
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	12.82	3.57	6.10	1.68	0.00	1.05	0.42	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	11.13	0.00	0.00	11.13	0.00	22.27	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	14.89	4.96	8.93	9.43	0.00	1.49	0.50	1.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	12.99	2.17	2.98	6.23	0.54	0.54	1.89	0.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	16.09	4.53	6.80	3.63	0.68	0.91	0.68	0.91
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	13.06	2.78	5.06	3.43	0.33	1.14	0.65	1.14
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	7.84	3.28	3.46	5.65	0.00	0.91	0.55	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	21.22	4.24	5.30	5.83	0.53	1.59	1.59	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	16.81	2.40	7.20	3.00	1.20	1.20	1.20	1.20
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	3.94	4.27	1.97	21.00	0.33	0.98	2.63	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	14.80	2.28	5.69	5.04	0.49	0.65	0.33	1.79
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	13.05	7.06	3.35	2.82	0.35	1.06	0.18	0.71
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	11.25	2.11	4.22	3.52	0.00	0.70	2.11	4.22
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	15.17	4.14	11.49	4.60	0.00	0.92	1.84	2.76
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	20.89	2.57	6.11	7.39	0.64	0.64	1.93	1.29
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	7.59	3.45	1.72	21.04	1.38	0.00	5.17	1.03
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	12.64	20.23	5.06	25.28	0.00	2.53	7.59	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	9.36	5.12	4.23	1.56	0.67	1.11	0.22	0.67
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	12.70	1.27	3.81	2.12	0.85	1.27	0.42	1.69
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	7.36	2.85	6.17	9.49	0.24	0.00	0.47	0.95
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	25.33	2.15	6.01	3.86	0.86	0.86	4.29	1.29
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	18.06	0.00	0.00	18.06	0.00	0.00	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	20.99	5.66	4.33	2.67	0.33	0.67	2.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	7.66	5.86	4.06	4.06	0.00	0.90	0.90	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	8.33	1.59	2.38	6.35	0.00	0.00	0.40	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	25.07	0.93	3.71	1.86	0.00	0.00	0.93	1.86
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	14.00	2.65	3.78	6.81	0.00	1.51	3.41	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	13.04	3.91	3.58	4.89	0.65	0.65	0.98	1.30
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	22.66	5.23	2.61	1.74	0.87	3.05	0.00	1.74
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	7.69	2.71	3.17	0.90	0.00	0.90	0.45	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	7.06	5.29	1.76	4.41	0.00	0.88	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	21.28	1.33	3.99	7.98	0.00	1.33	0.00	3.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	20.83	0.99	5.95	2.98	0.00	1.49	0.50	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	22.97	2.68	4.59	1.53	0.38	0.77	1.91	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	11.49	3.33	4.23	4.84	0.60	1.21	1.51	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	6.19	3.76	1.77	3.54	0.00	1.11	0.66	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	13.55	3.39	5.42	2.71	0.68	2.03	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	25.55	5.11	0.00	15.33	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	29.26	2.44	4.27	3.66	0.00	1.22	1.83	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	14.79	2.52	3.15	1.57	0.00	1.89	0.94	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	14.22	0.61	2.12	3.63	0.00	0.00	0.61	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	13.45	1.58	1.58	5.54	0.00	1.58	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	2.27	7.94	0.00	18.14	0.00	1.13	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	15.17	25.29	5.06	30.35	0.00	0.00	5.06	0.00
Myoblast, donor1	11241-116D8	5.09	9.07	5.84	2.24	0.00	0.99	0.25	0.25
Myoblast, donor2	11322-117D8	9.59	7.86	7.48	6.90	0.38	0.77	0.77	1.34
Myoblast, donor3	11398-118D3	19.68	7.40	13.12	1.01	1.01	1.68	0.00	0.84
NK T cell leukemia cell line:KHYG-1	10777-110G3	20.14	14.45	9.78	0.73	0.15	0.58	0.15	0.00
Natural Killer Cells, donor1	11230-116C6	11.07	7.07	10.15	0.31	0.00	0.00	0.62	0.31
Natural Killer Cells, donor2	11311-117C6	18.09	10.86	12.97	8.14	0.30	0.90	1.51	0.30
Natural Killer Cells, donor3	11387-118C1	17.12	9.57	9.57	5.34	0.18	0.37	1.29	0.00
Neural stem cells, donor1	11275-116H6	7.26	2.54	3.99	0.73	0.00	1.09	0.00	0.00
Neural stem cells, donor2	11352-117H2	17.33	3.85	5.78	0.00	0.00	0.00	1.93	0.00
Neurons, donor1	11494-119E9	0.00	3.41	5.69	4.55	0.00	0.00	0.00	0.00
Neurons, donor2	11574-120E8	4.84	0.88	2.42	0.88	0.00	0.00	0.22	0.00
Neurons, donor3	11655-122E8	4.93	0.82	8.22	2.47	0.00	0.00	0.00	0.00
Neutrophils, donor1	11233-116C9	3.71	1.86	0.93	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	0.00	2.90	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	2.44	1.83	0.61	0.61	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	9.02	11.16	6.65	2.26	0.95	0.36	0.36	1.19
Nucleus Pulposus Cell, donor2	11409-118E5	11.40	8.14	9.77	3.58	0.98	1.30	0.65	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	7.02	6.02	9.63	3.61	0.40	1.00	1.00	0.60
Olfactory epithelial cells, donor1	11933-125I7	12.53	3.30	5.09	3.85	0.00	0.28	0.96	0.00
Olfactory epithelial cells, donor2	11934-125I8	14.33	8.11	13.03	11.58	0.00	1.88	2.46	1.45
Olfactory epithelial cells, donor3	11935-125I9	12.03	5.79	9.31	5.22	0.34	0.79	1.70	0.45
Olfactory epithelial cells, donor4	11936-126A1	13.64	9.16	6.23	4.97	0.39	1.17	1.07	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	11.43	4.81	3.61	0.60	0.00	0.00	1.20	0.00
Osteoblast - differentiated, donor1	11276-116H7	21.06	7.23	7.87	0.85	0.21	3.19	0.64	0.85
Osteoblast - differentiated, donor2	11353-117H3	21.72	3.43	8.00	16.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	22.97	9.93	10.55	7.45	0.62	4.97	0.62	0.62
Osteoblast, donor1	11277-116H8	20.33	13.29	20.91	0.78	0.00	1.56	0.78	0.39
Osteoblast, donor2	11354-117H4	12.64	12.64	15.45	5.62	0.00	0.70	0.70	0.00
Osteoblast, donor3	11426-118G4	20.79	6.58	10.31	1.96	0.00	2.49	1.42	0.53
Pancreatic stromal cells, donor1	11249-116E7	13.14	9.10	8.00	3.20	0.51	1.85	1.10	1.18
Pericytes, donor1	11491-119E6	13.02	12.13	12.46	2.11	1.45	2.78	0.56	0.45
Pericytes, donor2	11571-120E5	16.07	9.28	15.62	4.53	0.68	1.36	0.68	1.36
Pericytes, donor3	11652-122E5	17.29	10.58	16.68	5.09	1.42	0.61	1.83	0.81
Perineurial Cells, donor1	11499-119F5	15.60	12.66	11.53	0.79	0.45	1.92	0.23	0.23
Perineurial Cells, donor2	11579-120F4	10.67	3.50	5.61	1.01	0.83	0.92	0.18	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	9.56	7.65	12.75	1.27	0.00	0.00	0.64	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	6.12	4.41	6.61	4.41	0.00	0.00	1.22	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	12.29	8.02	9.19	2.33	0.00	0.39	0.52	0.00
Placental Epithelial Cells, donor1	11278-116H9	25.59	14.59	8.61	3.83	0.24	3.35	0.48	0.00
Placental Epithelial Cells, donor2	11355-117H5	31.05	15.52	16.63	9.98	0.00	3.33	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	36.71	9.62	14.53	4.91	0.59	1.77	2.75	0.79
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	6.33	1.90	2.53	10.44	0.00	0.63	3.48	0.32
Preadipocyte - breast, donor1	11467-119B9	3.75	2.63	1.31	2.06	0.00	0.75	0.19	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	5.35	3.52	1.44	0.00	0.26	0.26	0.00	0.00
Preadipocyte - breast, donor2	11328-117E5	13.51	4.28	3.38	8.56	0.00	1.13	0.45	0.00
Preadipocyte - omental, donor1	11468-119C1	6.07	2.13	0.85	1.70	0.00	0.53	0.00	0.00
Preadipocyte - omental, donor2	11329-117E6	7.42	3.49	3.49	1.75	0.00	0.44	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	11.89	4.15	2.01	1.43	0.00	1.15	0.29	0.00
Preadipocyte - perirenal, donor1	11469-119C2	9.84	0.00	0.98	3.94	0.00	0.00	0.98	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	18.12	11.36	9.21	0.61	0.00	2.15	0.61	0.92
Preadipocyte - subcutaneous, donor2	11356-117H6	16.11	12.22	24.79	13.81	0.18	1.59	1.77	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	15.67	7.15	9.88	5.62	0.17	2.55	1.02	0.51
Preadipocyte - visceral, donor1	11280-116I2	9.59	12.02	13.04	1.86	0.37	1.96	0.56	0.65
Preadipocyte - visceral, donor2	11357-117H7	14.27	7.36	18.87	6.44	0.92	0.46	0.46	0.00
Preadipocyte - visceral, donor3	11429-118G7	10.87	7.31	10.03	8.99	0.31	0.73	2.09	0.63
Prostate Epithelial Cells (polarized), donor1	11253-116F2	21.27	20.67	25.64	10.86	18.25	3.77	4.37	0.60
Prostate Epithelial Cells, donor2	11331-117E8	11.51	6.50	8.67	8.53	0.41	1.08	0.81	0.95
Prostate Epithelial Cells, donor3	11404-118D9	14.82	20.09	6.98	4.72	0.06	1.10	0.67	0.31
Prostate Stromal Cells, donor1	11254-116F3	7.86	16.06	21.87	3.64	0.68	0.80	1.25	2.51
Prostate Stromal Cells, donor2	11332-117E9	10.94	12.73	21.70	6.81	0.54	1.97	1.61	1.61
Prostate Stromal Cells, donor3	11405-118E1	17.73	8.97	11.05	3.96	0.83	1.77	2.09	1.15
Renal Cortical Epithelial Cells, donor1	11516-119H4	14.96	12.41	16.79	2.92	0.00	2.92	1.09	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	9.63	4.78	4.57	2.15	0.35	0.76	0.90	0.14
Renal Epithelial Cells, donor1	11517-119H5	29.93	19.78	37.54	0.00	5.07	1.52	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	10.67	2.13	20.63	6.40	2.85	0.71	1.42	0.00
Renal Epithelial Cells, donor3	11678-122H4	8.79	5.29	6.88	2.33	0.53	0.85	0.21	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	14.30	2.72	14.98	4.77	0.00	4.77	2.04	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	7.28	2.29	10.38	2.29	0.00	0.81	0.67	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	6.66	3.77	13.54	5.11	0.00	1.33	1.11	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	17.30	5.32	17.30	7.32	0.67	2.00	1.33	0.00
Renal Mesangial Cells, donor1	11518-119H6	14.97	11.88	17.61	1.76	1.98	1.10	0.66	0.00
Renal Mesangial Cells, donor2	11598-120H5	18.81	9.40	17.56	2.51	1.88	1.25	1.25	0.00
Renal Mesangial Cells, donor3	11679-122H5	20.53	12.76	19.70	4.16	2.22	0.28	2.50	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	11.27	8.05	14.76	0.27	2.42	0.81	0.27	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	4.22	4.64	9.28	4.64	0.84	0.42	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	17.93	9.06	18.71	4.05	2.70	0.77	1.35	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	10.89	5.44	5.44	0.26	0.00	0.26	0.78	0.78
Retinal Pigment Epithelial Cells, donor1	11528-119I7	4.83	1.42	1.42	1.14	0.28	0.28	0.28	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	7.20	8.23	5.15	3.09	0.00	4.12	2.06	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	3.51	3.01	1.25	1.76	0.75	0.75	0.25	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	17.77	13.50	23.39	1.87	58.13	8.95	0.94	3.88
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	4.47	4.47	9.83	0.89	0.00	0.89	0.00	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	0.55	3.30	2.20	3.30	0.00	0.55	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	1.16	3.48	1.74	0.00	0.00	0.00	0.00	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	2.99	6.50	3.38	2.73	0.26	0.65	0.13	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	12.12	9.73	5.26	6.06	0.30	1.09	1.79	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	9.70	8.25	5.13	1.23	0.67	0.67	0.22	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	5.58	10.30	2.85	1.98	0.25	0.62	0.87	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	11.65	14.10	7.46	7.69	0.12	0.58	1.75	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	9.25	11.79	6.01	3.47	0.00	0.23	1.85	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	5.48	9.04	3.83	2.46	0.14	0.68	0.68	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	10.44	9.38	4.84	5.60	0.15	0.45	0.45	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	9.14	8.60	4.12	0.54	0.00	1.25	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	7.17	7.60	3.73	2.44	0.14	0.86	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	13.63	10.73	5.90	6.87	0.00	0.75	1.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	12.39	8.41	5.97	4.43	0.66	0.22	0.89	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	4.59	7.65	3.44	2.29	0.00	0.19	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	8.20	12.20	4.66	6.06	0.56	0.65	0.75	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	4.70	6.76	3.19	0.38	0.19	0.75	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	4.78	7.43	3.72	1.73	0.53	0.53	0.27	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	10.32	11.39	5.26	2.82	0.49	0.49	1.07	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	10.69	7.07	5.54	0.95	0.19	0.76	0.95	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	4.06	7.58	4.16	1.39	0.21	0.53	0.75	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	6.17	10.09	3.92	4.48	0.00	1.12	1.12	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	8.89	7.86	6.67	1.71	0.51	0.68	1.88	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	4.19	4.74	3.28	2.01	0.00	0.73	1.09	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	12.39	9.81	6.25	5.89	0.12	0.61	1.35	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	15.72	10.21	3.90	3.09	0.40	1.07	1.48	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	2.59	7.78	5.66	2.36	0.24	1.42	0.47	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	10.12	10.52	5.56	7.54	0.00	0.60	1.39	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	12.63	8.42	4.21	2.81	0.00	0.47	1.64	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	6.43	7.88	3.94	1.87	0.21	0.83	0.83	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	6.19	9.07	5.53	9.51	0.44	0.66	1.99	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	12.12	7.94	4.60	2.30	0.00	0.84	0.84	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	4.17	7.13	4.44	2.42	0.27	1.08	0.13	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	10.39	8.34	5.28	2.90	0.17	0.34	0.68	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	10.80	5.59	5.59	1.74	0.58	0.77	1.16	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	5.85	9.28	3.78	3.61	0.00	0.17	1.03	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	9.19	9.05	6.17	2.88	0.27	1.23	0.96	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	8.87	5.58	5.75	3.45	0.00	0.99	1.31	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	4.94	6.65	2.73	1.53	0.00	0.68	1.19	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	14.35	14.06	7.10	2.22	0.15	0.44	2.07	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	11.20	6.66	4.53	1.07	0.27	0.80	0.80	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	5.95	9.26	2.49	0.41	0.28	0.83	0.83	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	16.91	6.43	4.29	4.05	0.24	0.24	2.86	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	10.08	8.67	2.82	0.60	0.20	1.21	1.01	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	8.66	7.16	2.83	3.01	0.00	0.47	0.47	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	11.53	9.78	10.48	2.45	0.35	3.84	2.10	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	8.46	5.44	7.56	3.02	0.30	0.60	1.81	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	9.91	5.63	4.41	3.67	0.12	0.98	0.49	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	14.41	11.21	7.28	2.04	0.44	2.18	0.87	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	18.86	6.08	4.87	2.43	0.00	3.65	1.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	5.12	8.74	3.32	3.01	0.00	0.30	0.60	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	15.61	15.15	9.73	5.65	0.45	0.68	1.58	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	16.47	13.48	7.19	4.19	0.00	2.10	1.50	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	6.85	8.15	6.85	3.66	0.24	0.94	0.83	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	16.44	8.54	7.26	5.12	0.43	2.56	0.00	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	18.63	5.41	3.61	4.21	0.00	2.40	0.00	0.00
Schwann Cells, donor1	11498-119F4	20.31	10.91	25.01	5.27	0.38	2.44	2.44	0.19
Schwann Cells, donor2	11578-120F3	6.80	0.00	6.80	13.61	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	8.98	6.35	12.49	5.70	1.10	2.19	3.07	0.00
Sebocyte, donor1	11220-116B5	21.91	18.08	10.41	2.74	0.55	0.55	0.00	1.64
Sebocyte, donor2	11301-117B5	11.03	13.33	10.57	3.68	0.00	0.00	0.00	0.46
Sebocyte, donor3	11378-118B1	19.79	14.63	6.39	3.09	0.82	2.06	1.03	1.24
Sertoli Cells, donor1	11255-116F4	11.60	11.60	4.97	1.66	0.00	0.00	0.00	1.66
Sertoli Cells, donor2	11333-117F1	8.47	5.65	5.65	16.95	0.00	2.82	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	18.74	16.98	14.43	3.52	2.11	2.55	0.53	0.79
Skeletal Muscle Cells, donor2	11358-117H8	17.35	10.12	5.78	1.45	0.00	1.45	1.45	0.00
Skeletal Muscle Cells, donor3	11430-118G8	30.10	16.72	36.79	5.85	0.84	3.34	1.67	0.00
Skeletal Muscle Cells, donor4	11451-119A2	8.01	6.76	15.55	5.18	1.89	1.89	2.36	0.47
Skeletal Muscle Cells, donor5	11455-119A6	11.74	6.99	12.93	6.99	3.12	0.74	1.49	0.74
Skeletal Muscle Cells, donor6	11459-119B1	11.85	6.31	19.55	5.08	1.69	1.23	0.92	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	11.72	10.58	15.12	3.02	3.02	3.02	1.26	0.63
Skeletal Muscle Satellite Cells, donor2	11321-117D7	16.12	11.13	21.69	10.27	2.43	1.85	1.85	1.57
Skeletal Muscle Satellite Cells, donor3	11397-118D2	20.54	10.22	20.24	4.76	1.88	1.19	0.99	0.99
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	14.15	10.78	13.48	1.77	1.69	2.53	0.42	0.76
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	34.02	34.02	23.88	2.90	0.72	3.62	0.00	1.45
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	11.15	4.82	13.48	4.13	0.55	0.96	0.69	0.28
Skin - palm, donor1	10286-104F7	16.12	8.06	24.17	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	5.19	4.18	6.92	5.77	0.00	0.86	2.16	0.72
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	3.27	11.45	5.73	13.90	0.00	1.64	1.64	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	9.48	7.01	17.53	19.34	0.52	1.43	3.76	0.65
Small Airway Epithelial Cells, donor1	11256-116F5	7.65	15.15	14.87	5.28	0.70	2.50	0.97	0.42
Small Airway Epithelial Cells, donor2	11334-117F2	14.07	16.60	14.91	8.72	0.14	1.13	2.39	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	16.07	31.29	32.14	4.23	0.00	2.11	0.00	0.63
Small Airway Epithelial Cells, donor3	11406-118E2	23.46	25.48	16.86	5.92	0.45	2.62	1.42	0.22
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	11.42	15.74	21.91	10.18	0.31	2.16	2.16	0.62
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	2.89	9.34	6.23	1.33	0.22	0.89	0.00	1.56
Smooth Muscle Cells - Aortic, donor0	11210-116A4	15.28	9.99	14.11	0.00	0.00	0.00	1.76	1.76
Smooth Muscle Cells - Aortic, donor1	11283-116I5	16.57	8.40	9.28	0.88	0.22	1.77	0.22	1.10
Smooth Muscle Cells - Aortic, donor2	11360-117I1	13.78	6.69	10.24	0.79	1.18	1.18	0.00	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	15.45	7.73	13.91	0.77	0.77	3.09	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	12.01	9.01	8.01	5.00	1.00	1.00	3.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	10.78	5.19	5.99	0.93	0.27	0.67	0.27	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	12.41	7.54	9.53	4.88	1.33	1.55	1.55	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	7.68	3.58	5.25	1.02	0.13	1.15	0.13	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	11.40	7.16	8.79	1.95	0.98	3.26	0.00	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	11.81	5.61	5.32	0.89	0.00	0.89	0.00	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	12.53	3.70	3.42	1.14	0.28	0.71	0.43	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	13.99	7.97	14.80	1.30	0.81	2.93	0.65	1.79
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	7.61	6.09	10.66	2.44	0.61	0.91	1.22	2.13
Smooth Muscle Cells - Carotid, donor1	11285-116I7	26.27	16.42	11.87	1.01	0.51	1.77	0.51	1.26
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	11.44	4.29	11.92	4.29	0.95	0.00	2.86	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	8.41	9.44	9.44	1.03	1.33	1.18	0.74	0.44
Smooth Muscle Cells - Colonic, donor2	11320-117D6	9.26	7.32	10.12	5.17	0.65	0.86	1.29	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	12.91	8.08	11.65	4.41	1.78	0.63	1.26	1.15
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	15.47	6.65	8.51	0.77	0.62	1.55	0.62	0.62
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	6.47	10.78	8.62	2.16	0.00	2.16	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	5.98	6.87	8.07	1.79	0.30	0.30	0.90	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	15.02	18.09	30.73	1.02	2.05	1.37	0.68	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	8.01	10.92	8.25	1.18	1.81	0.47	0.31	1.49
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	9.66	7.25	6.74	4.63	0.10	1.81	0.20	0.70
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	7.05	12.29	14.79	7.74	0.68	0.46	1.59	2.50
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	6.04	6.64	9.06	3.62	0.00	0.60	0.60	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	9.01	11.13	32.32	1.85	1.06	0.79	0.53	1.32
Smooth Muscle Cells - Prostate, donor1	11257-116F6	8.39	13.18	14.65	2.00	0.13	1.07	0.27	0.80
Smooth Muscle Cells - Prostate, donor2	11335-117F3	10.89	13.77	20.54	7.51	1.00	1.38	1.38	1.75
Smooth Muscle Cells - Prostate, donor3	11465-119B7	13.70	6.60	5.83	0.25	0.51	1.01	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	16.43	14.02	22.31	1.06	0.45	1.96	0.75	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	25.51	11.25	9.00	3.00	0.75	2.25	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	37.47	1.29	10.34	1.29	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	13.02	8.37	12.56	1.40	0.00	0.93	0.47	1.40
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	7.57	7.07	6.06	7.07	1.51	0.00	1.01	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	6.58	5.33	7.21	5.95	0.31	0.94	0.00	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	6.49	10.32	9.44	2.36	1.77	0.59	0.00	1.47
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	16.24	14.50	30.82	1.25	0.58	1.92	0.42	0.83
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	14.01	6.54	7.94	3.27	0.93	2.34	0.47	1.40
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	12.23	3.60	3.31	0.29	0.14	0.72	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	21.42	5.35	10.20	2.55	0.51	1.27	0.51	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	16.55	3.95	12.79	2.82	0.19	0.94	0.56	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	12.16	9.92	11.60	0.56	0.56	0.98	0.14	0.42
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	16.51	9.72	13.24	0.92	1.09	1.01	0.34	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	10.00	24.29	11.90	0.95	0.48	0.95	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	11.50	4.40	4.40	0.00	0.24	0.00	0.24	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	9.94	5.08	9.50	0.88	0.22	2.43	0.44	0.66
Smooth Muscle Cells - Uterine, donor3	11466-119B8	17.55	14.92	26.33	7.02	0.88	2.05	0.00	0.88
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	7.97	6.03	3.69	7.19	0.19	0.58	0.97	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	3.44	5.29	3.70	6.08	0.00	0.26	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	0.74	2.60	0.74	21.20	0.37	0.74	2.60	1.12
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	6.11	9.70	5.39	5.75	0.00	1.08	0.00	2.16
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	2.56	3.41	0.85	2.84	0.00	0.00	0.00	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	6.70	7.09	13.39	6.30	0.79	1.97	0.79	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	4.06	5.84	2.54	10.92	0.76	0.25	0.00	1.78
Smooth muscle cells - airway, control, donor2	11967-126D5	7.99	7.59	3.59	6.39	0.80	0.00	0.40	2.80
Smooth muscle cells - airway, control, donor3	11968-126D6	7.11	4.18	2.09	15.05	0.42	0.84	1.25	1.67
Smooth muscle cells - airway, control, donor4	11969-126D7	9.17	3.21	3.67	5.04	0.46	1.83	1.38	0.00
Synoviocyte, donor1	11291-117A4	7.91	6.90	4.38	3.20	0.00	0.50	0.50	0.17
Synoviocyte, donor2	11368-117I9	28.83	15.09	14.42	9.39	1.01	3.86	2.85	4.53
Synoviocyte, donor3	11440-118H9	15.86	11.39	9.16	10.72	0.00	2.68	2.90	1.56
Trabecular Meshwork Cells, donor1	11532-120A2	16.79	15.01	27.16	2.50	1.07	2.86	0.36	0.71
Trabecular Meshwork Cells, donor2	11612-122A1	3.96	31.71	15.86	3.96	3.96	0.00	7.93	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	15.51	17.60	22.92	2.55	1.39	0.46	0.69	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	8.75	13.33	12.11	0.43	0.07	1.51	0.22	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	13.14	14.30	16.24	1.93	0.39	1.93	1.55	0.77
Tracheal Epithelial Cells, donor3	11441-118I1	7.44	10.31	18.90	1.15	0.00	1.15	1.15	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	19.93	15.26	25.47	2.21	61.64	6.64	1.11	5.66
Urethra, donor2	10319-105A4	14.39	5.40	1.80	0.00	0.00	1.80	0.00	0.00
Urothelial Cells, donor1	11520-119H8	8.50	7.70	6.91	1.33	0.27	0.80	0.00	0.00
Urothelial Cells, donor2	11600-120H7	6.81	6.01	5.21	2.00	0.40	0.00	2.40	0.00
Urothelial Cells, donor3	11681-122H7	13.06	9.63	9.86	2.98	0.00	1.38	1.15	0.46
Urothelial cells, donor0	11216-116B1	14.27	11.81	6.91	0.89	0.00	0.89	0.22	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	3.56	4.45	14.24	5.34	0.00	0.00	0.89	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	7.15	2.86	10.01	2.86	0.00	0.00	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	8.90	2.74	13.01	3.42	0.00	0.00	2.74	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	12.40	8.61	7.92	1.72	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	5.81	7.55	6.97	0.58	0.00	0.58	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	4.16	5.21	10.41	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	5.51	9.18	11.93	3.67	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	10.04	2.74	3.65	2.74	0.00	0.00	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	14.80	9.75	18.13	1.97	0.37	1.73	0.74	0.74
Wilms' tumor cell line:HFWT	10597-108E3	8.80	10.56	7.92	0.00	0.88	1.76	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	30.45	21.79	14.80	5.31	0.28	1.40	0.56	0.84
achilles tendon, donor2	10292-104G4	4.13	4.13	0.00	2.07	2.07	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	4.59	4.59	4.33	0.25	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	7.43	2.55	1.16	0.23	0.00	0.23	0.46	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	18.04	10.92	21.84	1.19	0.12	0.59	0.47	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	11.43	1.36	0.54	0.82	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	10.68	6.75	60.71	10.40	6.18	1.12	1.97	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	15.65	13.96	24.32	5.08	0.63	0.21	0.63	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	7.62	8.98	16.88	4.36	0.27	0.27	0.27	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	12.34	14.98	7.93	6.17	2.20	1.32	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	13.48	11.03	32.26	6.94	0.41	0.41	0.82	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	27.18	8.54	19.80	0.39	1.55	1.16	0.00	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	10.30	14.72	13.98	6.26	7.91	1.10	1.10	0.55
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	0.00	27.30	11.70	7.80	7.80	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	9.06	7.20	37.88	4.65	0.70	0.70	0.46	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	12.43	9.58	4.92	2.85	2.07	0.52	0.78	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	14.32	12.57	11.11	6.14	4.38	0.29	0.58	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	9.76	10.69	9.30	3.72	2.79	0.46	0.46	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	3.29	9.87	16.45	6.99	2.06	1.65	1.23	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	31.62	20.26	49.42	6.14	3.68	1.53	0.92	1.84
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	40.11	50.78	36.27	12.37	8.96	0.85	1.28	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	38.52	49.74	33.06	4.85	6.67	0.91	0.30	1.52
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	38.03	52.71	33.70	2.41	7.46	2.41	0.72	1.44
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	11.58	14.70	22.94	12.03	7.35	0.89	2.23	0.89
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	4.67	10.34	14.01	3.00	0.00	0.67	0.33	1.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	7.43	5.57	89.19	1.86	0.00	1.86	1.86	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	7.91	6.40	33.90	5.27	0.00	1.51	0.00	0.75
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	10.47	6.11	15.26	2.62	0.00	0.44	0.87	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	3.75	1.87	28.12	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	10.36	15.78	5.65	1.18	1.65	0.94	1.18	0.47
adipose tissue, adult, pool1	10010-101C1	12.41	5.74	3.41	1.71	0.31	2.17	1.09	0.78
adipose, donor1	10184-103D4	4.69	2.93	7.04	12.90	0.00	0.00	2.35	0.59
adipose, donor2	10185-103D5	11.76	16.63	20.68	5.68	0.00	2.84	0.81	0.41
adipose, donor3	10186-103D6	11.44	19.60	17.15	10.62	0.27	2.18	1.09	0.27
adipose, donor4	10187-103D7	4.33	5.20	5.20	4.33	0.00	1.73	3.47	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	21.46	8.68	3.47	1.26	0.00	0.95	0.00	0.16
adrenal gland, adult, pool1	10081-102A9	14.55	0.00	10.91	7.28	0.00	0.00	3.64	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	14.01	4.80	0.93	1.20	0.00	0.53	0.00	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	22.15	5.36	3.93	2.14	0.00	0.36	1.43	0.00
amniotic membrane cells, donor1	12235-129G3	19.01	7.42	3.71	3.01	0.23	0.70	0.46	0.00
amniotic membrane cells, donor2	12236-129G4	36.18	7.44	5.07	8.11	0.00	0.68	0.00	0.00
amniotic membrane cells, donor3	12237-129G5	16.79	9.43	2.36	3.83	0.00	1.18	0.59	0.00
amygdala - adult, donor10196	10167-103B5	1.19	7.11	0.00	2.37	0.00	1.19	0.00	0.00
amygdala, adult, donor10252	10151-102I7	8.72	3.65	1.82	1.62	0.00	0.20	0.00	0.00
amygdala, newborn, donor10223	10360-105E9	0.97	4.20	3.87	1.29	0.32	0.65	0.32	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	13.37	30.18	18.08	1.27	0.25	1.40	0.13	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	3.97	0.88	1.32	0.44	0.44	0.44	0.22	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	8.68	12.36	7.35	0.67	0.67	1.34	0.33	1.00
aorta, adult, pool1	10052-101G7	19.42	9.22	3.92	2.35	0.00	0.98	1.18	0.39
appendix, adult	10189-103D9	7.37	5.05	7.37	0.78	0.00	1.16	0.00	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	3.44	4.13	1.72	1.38	8.25	0.69	0.34	0.69
artery, adult	10190-103E1	20.38	4.08	1.36	13.59	0.00	0.00	8.15	6.79
astrocytoma cell line:TM-31	10425-106D2	12.60	7.24	6.52	1.45	0.00	0.43	0.43	0.29
b cell line:RPMI1788	10427-106D4	3.12	2.68	1.04	0.00	0.15	0.15	0.15	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	8.32	3.33	2.77	1.94	0.00	1.11	0.00	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	18.26	10.52	7.05	1.39	0.30	1.89	0.60	0.20
bile duct carcinoma cell line:TFK-1	10496-107C1	6.36	6.19	2.34	1.17	5.19	0.50	0.50	1.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	24.61	41.38	30.76	3.36	1.68	2.24	1.68	0.00
bladder, adult, pool1	10011-101C2	12.39	13.47	3.04	0.98	0.11	0.54	0.54	0.54
blood, adult, pool1	10053-101G8	26.58	6.64	11.07	0.00	0.00	2.21	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	15.41	5.14	5.99	0.00	0.00	1.71	0.00	0.00
bone marrow, adult	10192-103E3	8.10	4.72	4.05	3.37	0.00	0.00	1.35	0.00
brain, adult, donor1	10084-102B3	7.18	3.08	1.03	1.03	2.05	1.03	0.00	1.03
brain, adult, pool1	10012-101C3	4.79	3.34	1.45	1.00	0.22	0.22	0.56	0.22
brain, fetal, pool1	10085-102B4	5.34	2.67	2.67	2.67	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	29.40	30.72	25.44	9.58	0.33	3.63	2.97	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	58.17	77.64	19.47	5.12	2.00	8.99	1.50	6.99
breast, adult, donor1	10080-102A8	14.52	3.79	0.00	3.16	0.00	0.63	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	32.39	30.74	37.22	6.48	0.25	3.30	1.27	3.30
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	25.36	18.24	15.15	2.16	0.62	2.47	1.24	1.24
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	5.53	17.27	8.98	12.20	0.69	1.15	2.99	0.46
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	39.46	43.58	34.86	7.50	5.08	6.05	2.18	9.44
carcinoid cell line:NCI-H1770	10703-109H1	12.69	6.58	0.00	1.88	0.47	0.00	0.47	0.47
carcinoid cell line:NCI-H727	10735-110B6	6.02	11.48	7.33	1.20	0.66	1.09	0.11	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	10.14	4.75	3.17	2.85	0.00	0.32	0.32	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	11.45	14.64	13.58	7.72	0.00	1.33	0.80	0.00
caudate nucleus - adult, donor10196	10177-103C6	3.45	1.15	0.00	0.00	0.00	1.15	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	6.53	2.18	0.50	1.51	0.00	0.33	0.84	0.17
caudate nucleus, adult, donor10258	10379-105H1	3.06	3.82	0.76	0.00	0.00	0.00	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	0.73	1.46	2.56	0.73	0.00	0.37	0.00	0.00
cerebellum - adult, donor10196	10173-103C2	2.91	5.83	0.00	2.91	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	9.82	4.91	1.28	2.35	0.00	0.00	0.21	0.21
cerebellum, adult, pool1	10083-102B2	6.21	3.79	1.72	1.03	0.00	0.34	0.34	0.34
cerebellum, newborn, donor10223	10357-105E6	0.83	4.15	1.66	1.66	0.00	0.00	0.00	0.00
cerebral meninges, adult	10188-103D8	3.53	5.55	0.76	2.27	0.50	0.00	0.25	0.25
cerebrospinal fluid, donor2	10294-104G6	6.58	2.19	2.92	2.92	0.00	0.00	0.73	0.73
cervical cancer cell line:D98-AH2	10552-107I3	9.78	13.08	5.03	1.01	3.45	1.29	0.29	6.18
cervical cancer cell line:ME-180	10553-107I4	13.09	21.87	6.96	1.16	0.00	1.16	0.00	0.33
cervix, adult, pool1	10013-101C4	19.21	13.33	6.30	3.04	1.05	2.41	0.73	1.26
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	31.07	14.63	10.17	3.76	1.25	4.04	0.42	0.98
chondrosarcoma cell line:SW 1353	10700-109G7	5.23	1.31	5.23	0.00	1.31	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	7.21	12.43	3.85	2.11	0.37	0.37	0.25	0.00
choriocarcinoma cell line:SCH	10785-110H2	10.23	6.16	1.97	0.74	0.12	0.12	0.37	0.25
choriocarcinoma cell line:T3M-3	10618-108G6	5.46	8.30	1.42	0.47	0.00	0.24	0.24	0.24
chorionic membrane cells, donor1	12238-129G6	11.11	3.42	1.99	1.42	0.00	0.57	0.00	0.00
chorionic membrane cells, donor2	12239-129G7	12.63	6.26	5.17	4.28	0.10	0.80	0.10	0.20
chorionic membrane cells, donor3	12240-129G8	2.75	4.95	0.55	3.85	0.00	0.00	0.00	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	0.00	0.00	0.00	1.01	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	9.03	2.31	6.15	0.58	0.38	0.58	0.38	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	8.66	3.17	7.39	0.42	0.42	0.63	0.00	0.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	5.65	19.52	12.84	2.57	0.00	1.28	1.80	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	5.08	19.83	10.16	3.14	0.00	0.24	0.97	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	5.09	13.85	10.79	2.04	0.00	0.20	0.20	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	4.12	3.24	1.18	0.59	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	7.56	3.39	1.82	0.52	0.00	0.00	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	14.40	19.66	14.86	13.03	0.69	0.91	1.60	0.00
clear cell carcinoma cell line:TEN	10636-108I6	10.76	12.15	3.99	3.64	2.95	0.69	0.00	1.04
colon carcinoma cell line:CACO-2	10513-107D9	23.98	20.50	15.38	2.56	32.40	2.75	0.37	0.18
colon carcinoma cell line:COLO-320	10420-106C6	8.36	16.72	7.22	0.76	1.14	0.38	0.00	1.90
colon, adult, donor1	10082-102B1	20.23	8.33	3.57	1.19	0.00	3.57	0.00	0.00
colon, adult, pool1	10014-101C5	13.51	5.76	2.70	1.06	0.35	1.18	0.24	0.59
colon, fetal, donor1	10070-101I7	10.51	4.94	4.94	0.62	0.00	1.85	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	22.92	13.75	32.08	0.00	0.00	4.58	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	1.70	8.50	4.25	0.42	0.00	0.85	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	3.77	3.92	2.87	0.30	0.00	0.91	0.00	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	3.95	6.91	5.36	0.56	0.00	0.56	0.00	0.00
corpus callosum, adult, pool1	10042-101F6	8.40	5.31	1.55	0.22	0.11	0.55	0.11	0.44
cruciate ligament, donor2	10295-104G7	6.48	0.81	3.24	0.81	0.00	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	23.27	1.61	4.82	2.41	0.00	2.41	0.00	7.22
diencephalon, adult	10193-103E4	3.12	1.92	0.24	0.72	0.24	0.24	0.00	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	7.35	1.15	0.69	5.51	0.00	0.00	0.23	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	12.82	41.29	12.05	2.05	1.03	1.54	0.51	1.54
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	10.59	6.74	6.50	0.96	0.24	0.72	0.24	1.69
ductus deferens, adult	10196-103E7	14.45	13.46	2.99	4.98	0.00	2.49	1.99	1.99
duodenum, fetal, donor1, tech_rep1	10071-101I8	11.52	1.44	8.64	0.00	2.88	2.88	2.88	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	3.68	11.77	5.89	5.15	0.74	0.74	0.74	0.00
dura mater, adult, donor1	10041-101F5	19.74	20.65	13.38	1.82	3.30	2.31	1.24	2.73
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	4.00	22.65	10.66	2.22	0.00	1.55	0.22	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	5.88	8.45	8.45	2.87	0.14	1.43	0.00	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	14.18	16.03	12.33	1.23	0.00	0.00	0.62	2.47
embryonic pancreas cell line:1C3D3	10605-108F2	12.71	14.53	4.84	4.24	0.30	3.33	1.51	0.91
embryonic pancreas cell line:1C3IKEI	10606-108F3	11.73	21.92	8.34	4.32	1.54	2.78	0.93	2.47
embryonic pancreas cell line:2C6	10603-108E9	21.02	38.09	19.70	1.31	3.94	5.25	0.00	2.63
endometrial carcinoma cell line:OMC-2	10497-107C2	16.42	21.12	34.53	3.02	41.56	2.35	0.34	2.35
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	17.40	13.59	5.44	0.54	0.00	0.72	0.00	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	5.79	9.33	4.02	4.66	0.16	0.80	1.61	0.00
epidermoid carcinoma cell line:A431	10426-106D3	15.78	17.45	11.78	0.89	0.00	2.45	0.11	1.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	33.88	26.29	10.45	1.98	1.76	3.30	0.33	0.77
epididymis, adult	10197-103E8	15.28	10.67	5.65	6.70	0.42	1.67	0.21	0.84
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	26.26	4.44	4.26	1.60	0.00	1.42	0.71	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	7.08	7.08	11.80	1.57	0.39	1.57	0.39	1.18
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	16.25	18.35	8.65	7.34	2.36	2.75	2.36	3.67
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	17.81	26.87	9.05	5.61	2.46	3.15	1.77	2.66
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	17.36	21.51	13.67	9.63	2.69	2.80	2.02	4.15
esophagus, adult, pool1	10015-101C6	16.78	15.82	5.20	2.12	0.32	1.38	0.42	1.27
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	14.53	11.02	7.14	0.88	0.38	1.25	0.38	0.13
eye - muscle inferior rectus, donor1	10272-104E2	2.41	7.24	4.83	4.83	0.00	4.83	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	4.21	0.00	2.10	2.10	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	10.42	1.49	1.49	1.49	0.00	2.98	1.49	1.49
eye - muscle superior, donor2	10297-104G9	2.29	2.29	4.59	1.15	0.00	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	2.91	8.74	2.91	1.46	0.00	2.91	0.00	0.00
eye, fetal, donor1	10054-101G9	9.15	2.03	2.54	0.76	0.25	0.76	0.76	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	11.80	5.51	10.64	0.77	0.26	0.64	0.51	0.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	10.92	12.35	12.11	2.85	0.47	0.71	1.19	0.47
frontal lobe, adult, pool1	10040-101F4	5.07	7.32	1.60	0.00	0.09	0.28	0.09	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	16.81	22.52	12.91	0.90	0.90	1.50	0.60	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	14.36	18.10	20.85	1.46	0.46	3.75	0.37	0.00
gall bladder, adult	10198-103E9	16.90	11.11	6.04	3.86	0.24	1.69	0.48	0.48
gamma delta positive T cells, donor1	11937-126A2	20.40	11.27	14.50	5.91	0.00	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	16.81	11.20	8.59	5.23	0.37	0.37	0.37	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	14.15	15.42	19.22	10.14	1.06	2.75	2.11	1.48
gastric adenocarcinoma cell line:MKN45	10612-108F9	5.03	7.16	3.87	0.19	3.67	0.39	0.77	1.55
gastric cancer cell line:AZ521	10549-107H9	7.71	3.93	0.98	0.33	0.00	0.16	0.00	0.16
gastric cancer cell line:GSS	10560-108A2	20.13	25.63	7.32	3.66	4.58	5.49	0.00	3.66
gastrointestinal carcinoma cell line:ECC12	10615-108G3	4.57	3.66	6.40	2.97	1.60	0.23	0.69	0.00
giant cell carcinoma cell line:LU65	10487-107B1	1.03	1.95	0.34	0.57	0.46	0.34	0.00	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	12.74	10.36	14.56	0.98	5.46	0.84	0.00	2.10
glassy cell carcinoma cell line:HOKUG	10688-109F4	23.45	51.13	29.43	3.24	0.00	2.99	0.25	1.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	16.57	20.05	22.38	2.74	1.48	4.33	0.53	1.69
glioblastoma cell line:A172, tech_rep2	10444-106F3	27.25	21.07	22.61	0.70	1.54	2.53	0.14	1.12
glioblastoma cell line:T98G	10485-107A8	20.97	18.54	19.98	3.20	3.20	2.32	0.33	1.43
glioma cell line:GI-1	10413-106B8	15.52	17.57	10.54	2.64	1.17	1.46	0.00	0.59
globus pallidus - adult, donor10196	10175-103C4	2.92	2.19	2.92	0.00	0.00	0.73	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	4.88	2.20	0.24	0.73	0.00	0.98	0.24	0.00
globus pallidus, adult, donor10258	10367-105F7	1.37	1.37	0.00	0.00	1.37	1.37	4.11	0.00
globus pallidus, newborn, donor10223	10364-105F4	0.53	1.60	1.07	0.00	0.53	0.00	0.53	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	66.07	53.84	48.94	0.00	0.00	2.45	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	21.86	0.00	54.64	10.93	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	15.68	5.23	0.00	0.00	5.23	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	8.96	1.60	2.24	4.16	0.00	0.64	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	1.84	1.84	5.05	1.38	0.00	0.00	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	0.91	2.74	1.37	2.74	0.00	0.91	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	0.00	1.29	1.93	0.64	0.00	0.00	1.29	0.00
hIPS, biol_rep1	14380-156B6	0.00	7.19	4.31	0.00	2.87	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	0.69	2.06	4.12	1.37	0.00	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	4.41	1.10	4.41	0.00	0.00	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	6.03	8.91	2.59	0.86	0.00	0.00	0.29	0.00
heart - mitral valve, adult	10205-103F7	6.58	3.59	2.69	3.89	0.30	1.20	0.60	0.00
heart - pulmonic valve, adult	10206-103F8	17.00	14.64	3.92	2.88	0.00	1.57	1.05	1.05
heart - tricuspid valve, adult	10207-103F9	9.16	3.33	4.16	3.33	0.83	0.83	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	21.02	12.45	4.29	2.45	0.20	1.22	1.63	0.61
heart, adult, diseased, donor1	10051-101G6	12.35	4.68	0.85	5.96	0.00	1.28	1.28	0.85
heart, adult, pool1	10016-101C7	18.40	8.05	2.53	0.92	0.23	1.38	0.46	0.92
heart, fetal, pool1	10046-101G1	12.53	5.75	2.57	0.00	0.21	1.13	0.41	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	16.97	5.24	9.56	1.23	0.00	2.47	0.31	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	8.32	13.08	21.41	0.00	19.03	2.38	0.00	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	27.40	9.17	11.60	11.16	60.66	4.20	3.65	0.66
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	35.20	11.41	12.74	12.02	65.30	3.88	4.98	0.61
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	33.45	9.40	11.42	9.09	65.38	3.44	3.94	0.61
hepatoma cell line:Li-7	10484-107A7	7.34	9.34	4.67	0.89	3.89	1.22	0.22	0.33
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	15.38	12.16	9.55	0.80	0.40	0.90	0.50	0.30
hippocampus - adult, donor10196	10169-103B7	2.84	0.95	0.95	0.95	0.00	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	5.71	5.31	0.82	0.82	0.00	0.61	0.41	0.41
hippocampus, adult, donor10258	10374-105G5	0.00	0.50	1.00	1.00	0.00	1.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	2.82	2.47	1.06	2.11	0.00	0.35	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	5.49	3.05	0.61	9.16	0.00	0.61	1.22	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	5.50	6.87	0.98	6.28	0.00	0.79	1.37	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	5.33	5.59	2.03	4.57	0.00	1.27	0.51	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	4.51	10.71	12.97	5.07	0.56	0.56	0.56	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	9.81	13.94	11.10	12.91	0.26	0.77	1.03	0.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	4.56	14.43	13.29	9.11	0.00	1.52	1.14	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	5.55	16.64	18.10	13.43	0.58	2.34	0.58	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	12.93	22.62	30.59	12.49	0.00	2.59	0.43	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	10.43	20.85	32.11	7.51	0.42	3.34	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	16.58	27.94	40.25	9.23	0.95	1.89	0.47	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	21.54	28.13	43.88	23.14	0.80	2.73	1.93	0.80
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	14.14	25.59	28.95	7.41	0.67	2.69	1.35	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	5.01	2.82	2.03	3.13	0.16	1.10	0.78	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	2.46	3.44	0.98	5.90	0.49	0.00	2.46	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	0.87	0.87	0.00	6.98	1.75	0.87	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	8.59	10.50	10.88	6.49	0.19	0.76	0.38	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	8.72	7.41	9.16	1.74	0.00	0.44	0.87	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	3.50	5.50	9.00	11.49	0.00	1.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	5.65	21.48	24.87	9.23	0.38	0.94	1.51	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	9.09	23.65	23.65	10.46	0.00	1.82	2.27	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	5.33	16.91	22.24	14.72	0.31	2.19	0.94	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	12.08	18.78	21.88	12.74	0.16	2.45	0.65	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	15.97	18.58	20.90	14.23	0.00	1.74	1.74	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	12.26	19.43	25.11	19.73	0.00	2.39	0.60	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	4.43	5.91	5.17	4.43	0.00	0.74	0.00	0.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	4.85	5.99	3.14	6.56	0.00	0.86	0.29	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	3.27	5.31	3.67	8.57	0.00	1.22	0.82	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	8.80	13.03	14.08	16.90	0.00	1.06	0.70	1.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	10.77	9.50	13.62	9.19	0.63	2.53	0.63	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	3.03	13.32	16.04	12.10	0.61	2.72	3.03	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	11.89	16.03	28.96	8.79	1.03	1.55	0.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	11.29	21.25	30.55	9.30	0.00	2.66	1.33	2.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	8.47	17.70	21.04	10.52	0.00	2.57	0.26	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	13.04	13.55	20.96	19.94	0.00	2.56	1.53	1.02
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	17.42	16.66	28.77	18.17	0.00	2.27	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	7.39	14.45	26.55	10.08	0.00	2.02	0.34	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	6.04	8.45	3.62	5.80	0.00	0.72	0.24	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	3.57	6.68	3.12	4.46	0.45	0.89	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	4.88	5.37	7.32	7.32	1.46	0.49	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	7.33	12.84	22.00	7.95	0.00	1.53	0.61	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	3.25	6.51	3.25	39.04	0.00	3.25	6.51	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	2.65	10.26	10.92	10.59	0.66	0.99	2.32	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	13.68	21.34	43.24	11.49	0.00	1.64	1.09	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	10.86	21.71	23.16	17.01	0.00	2.17	1.81	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	7.83	17.08	23.13	15.66	0.71	2.14	3.91	0.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	10.74	9.55	34.61	26.25	0.00	3.58	1.19	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	13.41	27.49	45.64	12.19	0.41	3.66	1.35	0.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	11.31	17.24	30.71	12.12	0.81	2.16	2.42	0.00
immature langerhans cells, donor1	11904-125F5	1.45	0.48	0.24	0.48	0.00	0.00	0.24	0.00
immature langerhans cells, donor2	11905-125F6	4.75	7.13	0.00	3.17	0.00	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	6.15	5.87	1.04	0.00	0.09	0.38	0.28	0.19
keratoacanthoma cell line:HKA-1	10791-110H8	35.12	13.66	12.36	3.58	0.00	2.60	0.00	0.98
kidney, adult, pool1	10017-101C8	15.62	11.11	13.62	1.90	12.32	1.90	0.90	0.80
kidney, fetal, pool1	10045-101F9	12.45	14.01	16.84	0.92	19.17	2.26	0.57	0.78
large cell lung carcinoma cell line:IA-LM	10509-107D5	11.08	11.79	11.50	0.85	0.99	0.99	0.14	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	6.50	12.17	6.36	3.73	0.69	1.24	0.41	0.55
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	19.82	36.15	16.88	1.28	0.37	1.65	1.28	0.18
left atrium, adult, donor1	10079-102A7	10.90	4.36	1.09	1.09	0.00	0.54	0.54	0.54
left ventricle, adult, donor1	10078-102A6	14.16	5.56	4.55	1.52	0.00	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	16.69	10.67	12.04	0.82	0.82	0.82	0.27	1.09
leiomyoma cell line:10964C	10569-108B2	7.54	12.93	14.37	17.24	1.08	1.80	3.23	2.51
leiomyoma cell line:15242A	10570-108B3	4.89	9.78	9.24	9.24	0.00	0.00	0.54	1.09
leiomyoma cell line:15425	10571-108B4	8.74	11.90	20.88	17.73	0.00	1.21	3.16	3.16
leiomyosarcoma cell line:Hs 5.T	10722-110A2	0.00	6.35	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	10.46	8.36	2.09	5.23	0.00	1.05	1.05	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	5.31	0.71	1.06	0.24	0.12	0.00	0.00	0.00
liposarcoma cell line:KMLS-1	10782-110G8	19.21	14.84	8.28	3.59	0.62	1.25	1.09	2.34
liposarcoma cell line:SW 872	10726-110A6	35.94	21.20	36.92	3.41	2.44	3.66	1.58	0.85
liver, adult, pool1	10018-101C9	12.32	7.29	7.13	0.97	17.83	3.24	0.81	1.94
liver, fetal, pool1	10086-102B5	15.99	3.76	9.41	4.70	15.99	1.88	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	2.48	0.73	0.15	0.15	0.00	0.29	0.15	0.15
locus coeruleus, adult, donor10252	10165-103B3	3.51	1.29	0.74	0.74	0.00	0.18	0.37	0.00
locus coeruleus, adult, donor10258	10375-105G6	4.23	1.97	1.69	3.10	0.00	0.56	0.56	0.00
locus coeruleus, newborn, donor10223	10362-105F2	0.42	1.68	1.26	0.84	0.42	0.00	0.00	0.00
lung adenocarcinoma cell line:A549	10499-107C4	4.43	5.26	0.97	0.42	3.18	0.00	0.14	0.42
lung adenocarcinoma cell line:PC-14	10408-106B3	33.78	22.06	13.79	0.00	2.07	3.45	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	26.23	18.85	26.36	4.75	0.79	3.56	1.32	0.40
lung, adult, pool1	10019-101D1	10.87	6.62	2.95	1.18	0.24	1.42	0.47	0.12
lung, fetal, donor1	10068-101I5	2.85	5.99	7.71	0.29	0.86	0.86	0.00	0.00
lung, right lower lobe, adult, donor1	10075-102A3	13.29	3.21	7.33	3.21	0.46	1.37	0.00	0.00
lymph node, adult, donor1	10077-102A5	15.62	4.73	6.63	2.37	0.00	0.95	0.47	0.47
lymphangiectasia cell line:DS-1	10727-110A7	15.56	1.97	1.75	1.75	0.00	0.00	0.44	0.66
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	2.57	0.15	0.15	1.36	0.00	0.00	0.15	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	2.55	12.74	9.34	1.70	0.00	0.00	0.00	0.85
mature adipocyte, donor1	12231-129F8	55.50	27.08	12.88	4.00	0.89	7.55	0.00	7.10
mature adipocyte, donor2	12232-129F9	34.24	12.04	3.53	6.23	0.00	4.15	0.21	4.15
mature adipocyte, donor3	12233-129G1	35.32	14.93	6.40	6.16	0.71	6.16	0.00	3.32
mature adipocyte, donor4	12234-129G2	30.53	30.27	20.00	9.48	0.26	7.63	0.26	5.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	15.73	19.78	3.81	2.86	0.71	1.67	0.48	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	0.00	1.13	0.00	0.00	0.00	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	4.60	2.76	0.92	1.84	0.00	0.18	0.00	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	1.27	1.91	0.95	0.95	0.00	0.00	0.32	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	0.00	0.85	0.85	2.13	0.43	0.43	0.85	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	2.19	2.53	0.34	1.86	0.00	0.00	0.00	0.34
medial temporal gyrus, adult, donor10252	10156-103A3	6.58	2.76	1.49	1.49	0.00	0.42	0.64	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	1.93	1.93	1.93	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	0.36	3.95	1.44	0.36	0.36	0.00	0.36	0.36
medulla oblongata - adult, donor10196	10174-103C3	4.54	0.00	0.65	0.00	0.00	0.00	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	6.81	1.70	0.62	1.55	0.00	0.15	0.46	0.00
medulla oblongata, adult, pool1	10038-101F2	6.45	6.86	1.88	0.41	0.00	0.57	0.33	0.16
medulla oblongata, newborn, donor10223	10361-105F1	1.04	3.47	0.35	1.74	0.35	0.00	0.00	0.00
medulloblastoma cell line:D283 Med	10838-111E1	10.18	5.31	3.76	3.54	3.10	0.00	0.89	0.89
medulloblastoma cell line:ONS-76	10759-110E3	35.70	23.97	33.50	1.47	0.61	3.18	0.37	2.32
melanoma cell line:COLO 679	10514-107E1	2.73	0.72	0.43	0.57	0.00	0.00	0.00	0.00
melanoma cell line:G-361	10465-106H6	4.61	3.53	0.54	1.36	0.00	0.54	0.00	0.00
meningioma cell line:HKBMM	10691-109F7	4.16	4.34	2.71	6.87	0.00	0.18	0.18	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	3.52	3.52	2.64	5.29	0.00	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	3.63	6.48	3.37	2.59	0.00	0.00	0.26	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	11.81	4.91	5.83	2.45	0.46	1.38	0.61	0.61
mesenchymal precursor cell - adipose, donor2	11748-123G2	10.36	8.36	6.00	4.73	0.00	0.36	0.73	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	5.38	3.73	6.63	3.73	1.24	1.66	0.83	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	9.55	5.34	2.53	1.97	0.00	0.42	0.84	0.56
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	7.51	2.70	1.93	2.70	0.00	0.77	0.96	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	4.86	7.63	2.78	4.16	0.00	0.69	0.00	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	3.43	1.20	1.54	2.23	0.00	0.34	0.69	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	10.47	3.91	3.11	4.14	0.12	0.81	1.15	0.69
mesenchymal precursor cell - cardiac, donor3	11754-123G8	8.75	4.77	6.76	2.12	0.27	0.80	0.66	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	10.40	7.70	7.97	2.16	0.41	0.81	0.68	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	8.82	4.13	4.98	2.70	0.43	0.71	0.43	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	3.29	1.98	2.96	2.63	0.00	0.33	0.33	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	9.69	3.60	5.12	1.52	0.14	0.83	0.83	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	10.12	8.38	7.68	6.98	0.00	1.75	0.35	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	11.43	4.70	2.86	2.04	0.00	1.02	0.41	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	6.11	2.52	3.59	5.39	0.00	1.08	0.00	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	12.10	5.48	4.24	3.00	0.00	0.52	1.24	0.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	4.79	2.51	3.19	2.28	0.00	0.46	0.68	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	4.20	5.87	11.75	3.78	0.42	0.84	0.84	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	6.87	4.18	3.14	1.79	0.00	0.15	0.75	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	8.40	3.41	3.76	1.84	0.18	0.26	0.79	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	5.89	2.95	2.95	4.79	0.00	0.37	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	4.29	3.43	2.29	4.29	0.00	0.86	0.00	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	16.00	10.10	13.89	16.00	0.42	1.68	2.11	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	11.42	9.59	12.33	5.02	0.00	1.37	0.00	2.28
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	8.95	14.84	9.21	5.88	0.51	2.30	0.51	3.07
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	11.26	18.32	13.35	8.38	0.00	2.88	1.05	2.88
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	10.17	12.02	13.86	7.70	0.31	4.31	2.46	3.70
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	8.94	14.83	11.06	9.41	0.71	2.35	1.65	1.41
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	11.51	12.52	12.52	8.80	0.34	2.03	2.03	2.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	14.15	11.00	8.25	7.86	0.00	3.54	1.96	2.36
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	9.73	13.44	14.36	12.51	0.00	1.39	1.39	2.78
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	12.69	13.84	13.84	8.08	0.00	1.44	0.58	3.75
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	12.94	14.28	14.95	5.35	1.12	3.57	0.67	2.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	11.30	12.74	15.86	7.45	0.24	2.40	1.20	3.12
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	12.47	13.93	12.47	8.07	0.73	0.00	0.73	1.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	14.10	15.44	14.10	8.39	1.01	2.35	1.01	2.69
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	8.60	10.23	12.69	11.46	0.82	3.28	0.82	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	11.17	10.74	12.89	7.30	0.00	2.15	2.15	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	10.94	10.94	13.67	13.67	0.00	0.00	0.00	8.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	20.66	5.16	10.33	30.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	8.44	5.85	12.02	11.04	1.30	1.30	0.65	2.27
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	7.27	8.73	11.64	14.55	1.45	1.45	0.00	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	11.19	4.80	12.26	8.00	0.53	1.07	0.53	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	9.81	9.81	9.00	10.63	0.00	2.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	7.77	7.00	10.11	15.94	0.00	2.33	0.39	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	12.59	2.10	14.69	6.30	2.10	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	8.94	6.95	8.94	16.89	0.99	1.99	0.00	2.98
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	14.30	9.53	14.30	9.53	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	6.52	8.89	10.08	7.12	0.59	1.19	0.00	1.78
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	6.09	4.87	18.28	2.44	0.00	0.00	1.22	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	27.05	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	8.23	9.50	5.70	8.23	1.90	2.53	0.63	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	9.31	3.10	6.55	6.21	1.03	0.69	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	6.45	6.45	2.15	4.30	0.00	2.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	11.98	0.00	0.00	7.98	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	6.89	3.44	3.44	6.89	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	11.00	4.89	3.26	1.63	1.22	0.81	1.63	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	10.33	3.97	3.18	2.38	0.79	1.59	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	5.90	1.18	1.77	2.95	0.59	0.00	0.59	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	8.42	3.43	0.31	2.49	0.31	0.62	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	5.35	0.00	1.34	0.00	0.00	0.00	0.00	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	14.19	4.73	4.73	10.64	0.00	2.37	0.00	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	17.98	2.57	0.00	7.70	0.00	0.00	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	12.39	0.69	2.75	4.13	0.00	1.38	0.00	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	23.26	6.93	9.90	13.36	4.45	7.42	2.97	7.42
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	38.13	2.24	3.36	8.97	3.36	4.49	1.12	3.36
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	27.35	4.45	8.90	11.45	7.63	6.36	2.54	5.72
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	31.43	4.03	8.87	14.51	6.85	8.06	2.42	4.84
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	30.53	0.00	2.18	23.99	2.18	8.72	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	26.61	0.00	5.07	15.20	10.14	6.34	1.27	8.87
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	21.24	3.64	1.21	11.53	1.21	7.89	2.43	4.25
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	36.15	0.00	9.04	13.56	0.00	13.56	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	23.06	4.94	1.65	11.53	1.65	7.41	1.65	2.47
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	20.04	4.96	6.55	3.17	1.39	4.17	0.00	2.98
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	21.42	8.44	4.87	8.44	3.24	2.92	1.62	5.19
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	21.39	4.07	8.15	9.17	2.04	5.09	0.00	5.09
mesodermal tumor cell line:HIRS-BM	10696-109G3	9.28	3.87	3.09	0.00	0.00	0.77	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	45.12	61.90	15.83	3.07	1.18	2.83	0.24	0.94
mesothelioma cell line:ACC-MESO-4	10494-107B8	15.75	2.78	4.17	0.70	0.70	0.70	0.00	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	25.64	17.09	12.82	8.55	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	7.91	6.27	9.25	6.88	0.51	0.51	2.77	1.34
mesothelioma cell line:Mero-25	10850-111F4	9.76	20.43	37.22	9.53	1.13	3.40	2.04	0.45
mesothelioma cell line:Mero-41	10851-111F5	6.60	8.80	9.29	6.85	0.00	0.73	0.49	0.24
mesothelioma cell line:Mero-48a	10852-111F6	4.87	5.76	3.76	2.88	0.00	1.11	0.44	0.22
mesothelioma cell line:Mero-82	10853-111F7	17.61	24.70	29.70	6.31	1.05	2.63	2.37	0.26
mesothelioma cell line:Mero-83	10854-111F8	13.45	8.17	6.64	4.26	0.17	1.19	0.34	1.53
mesothelioma cell line:Mero-84	10855-111F9	12.39	7.58	20.98	7.84	2.02	2.78	0.00	0.76
mesothelioma cell line:Mero-95	10856-111G1	22.36	26.29	32.71	13.04	4.97	3.73	1.86	4.14
mesothelioma cell line:NCI-H2052	10847-111F1	23.52	13.58	24.18	9.11	0.50	3.48	1.82	0.17
mesothelioma cell line:NCI-H226	10846-111E9	13.03	14.84	25.34	6.33	0.90	1.09	1.99	2.17
mesothelioma cell line:NCI-H2452	10848-111F2	16.74	19.30	26.48	7.69	1.37	1.88	1.71	1.54
mesothelioma cell line:NCI-H28	10845-111E8	12.98	15.01	9.16	8.14	8.40	0.76	1.02	2.29
mesothelioma cell line:No36	10857-111G2	12.40	17.29	22.18	4.24	0.65	3.26	0.65	0.98
mesothelioma cell line:ONE58	10858-111G3	8.13	12.19	8.40	5.69	1.08	2.17	0.54	0.54
migratory langerhans cells, donor1	11901-125F2	1.54	4.61	0.96	0.96	0.00	0.00	0.19	0.00
migratory langerhans cells, donor2	11902-125F3	4.88	6.72	1.71	2.32	0.00	0.24	0.00	0.00
migratory langerhans cells, donor3	11903-125F4	3.77	4.67	1.26	2.51	0.00	0.18	0.18	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	18.94	38.20	17.30	19.92	0.00	0.98	2.61	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	23.10	7.84	10.81	6.99	2.12	0.85	1.27	0.85
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	11.29	28.10	21.65	0.69	0.00	0.46	0.69	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	8.18	0.95	1.14	0.95	0.00	0.19	0.00	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	19.59	11.46	4.07	4.62	3.88	1.29	0.55	0.18
myeloma cell line:PCM6	10474-106I6	10.67	2.57	1.38	0.99	0.00	0.40	0.40	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	23.84	19.28	11.16	1.52	1.01	1.01	0.00	1.01
myxofibrosarcoma cell line:NMFH-1	10684-109E9	31.19	15.50	5.49	3.73	0.00	1.37	0.59	1.57
nasal epithelial cells, donor1, tech_rep1	12226-129F3	13.04	27.30	10.14	1.56	0.11	1.34	0.56	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	5.52	20.30	7.13	3.02	0.00	0.88	0.74	0.00
nasal epithelial cells, donor2	12227-129F4	12.14	28.15	27.60	3.31	0.00	1.10	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	2.53	12.42	4.14	0.00	0.23	0.00	0.23	0.00
neuroblastoma cell line:NB-1	10539-107G8	12.72	9.92	13.66	0.94	0.94	1.12	0.56	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	10.54	29.74	7.59	6.33	4.01	1.27	1.27	0.21
neuroblastoma cell line:NH-12	10555-107I6	6.34	9.50	4.47	0.75	3.17	0.00	0.37	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	2.61	4.03	6.64	2.14	0.24	0.00	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	11.56	8.24	11.09	5.07	0.63	0.00	0.63	0.32
neuroectodermal tumor cell line:TASK1	10774-110F9	20.13	4.43	2.42	1.41	4.23	0.20	0.60	1.21
neuroepithelioma cell line:SK-N-MC	10728-110A8	12.08	1.27	3.81	0.00	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	13.31	3.46	7.19	1.06	0.00	0.80	0.00	0.53
neutrophil PMN, donor1	12133-128D9	29.75	14.87	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	9.47	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	7.27	2.37	9.47	0.34	0.00	0.34	0.00	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	1.60	4.80	3.20	0.00	0.00	0.80	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	24.37	9.62	15.71	3.53	0.00	0.96	0.32	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	8.93	10.25	9.20	10.77	0.53	0.79	1.05	1.31
nucleus accumbens, adult, pool1	10037-101F1	5.16	3.19	1.31	0.19	0.00	0.47	0.09	0.09
occipital cortex - adult, donor10196	10172-103C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.06
occipital cortex, adult, donor10252	10163-103B1	8.32	1.61	0.54	1.07	0.00	0.27	0.27	0.27
occipital cortex, newborn, donor10223	10355-105E4	0.00	1.09	2.18	0.36	0.00	0.00	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	4.20	1.31	0.26	0.79	0.00	0.26	0.00	0.00
occipital lobe, fetal, donor1	10073-102A1	0.43	2.15	6.44	0.86	0.00	1.72	0.00	0.00
occipital pole, adult, pool1	10036-101E9	4.49	5.36	1.50	0.32	0.00	0.55	0.00	0.08
olfactory region, adult	10195-103E6	3.44	2.67	1.15	0.57	0.38	0.00	0.38	0.38
optic nerve, donor1	10277-104E7	6.00	0.00	6.00	0.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	25.86	16.86	4.33	2.05	1.03	1.48	0.46	18.45
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	16.76	25.83	9.07	1.65	0.41	1.92	0.27	1.51
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	8.47	13.21	11.68	11.18	0.51	0.85	1.86	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	16.40	24.95	15.59	5.54	0.69	1.73	1.27	0.92
osteoclastoma cell line:Hs 706.T	10704-109H2	14.11	12.05	7.64	1.76	0.00	1.76	0.59	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	25.23	3.74	1.87	0.00	0.00	1.87	0.93	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	13.78	7.21	12.30	1.06	2.33	0.64	0.21	3.39
ovary, adult, pool1	10020-101D2	16.07	17.38	7.34	1.40	1.14	2.53	0.35	0.96
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	17.42	7.70	14.67	2.20	0.37	1.10	0.55	0.18
pancreas, adult, donor1	10049-101G4	15.05	1.88	0.00	0.94	0.94	1.88	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	10.06	10.34	6.15	1.68	0.28	1.96	0.28	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	20.10	15.84	16.52	15.16	1.02	2.73	1.70	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	9.27	13.58	8.11	1.49	0.00	0.66	0.50	0.17
paracentral gyrus, adult, pool1	10035-101E8	4.03	4.67	0.82	0.09	0.18	0.27	0.18	0.00
parietal cortex, adult, donor10258	10373-105G4	1.47	2.94	0.00	2.20	0.00	0.00	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	1.88	3.76	0.94	1.88	0.00	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	3.42	2.28	0.86	0.57	0.29	0.00	1.14	0.00
parietal lobe, adult, pool1	10034-101E7	4.05	4.76	0.88	0.00	0.18	0.70	0.00	0.35
parietal lobe, fetal, donor1	10072-101I9	0.00	1.94	1.94	0.00	0.00	0.00	0.00	0.97
parietal lobe, newborn, donor10223	10356-105E5	2.62	0.37	1.12	0.75	0.00	0.00	0.37	0.37
parotid gland, adult	10199-103F1	14.18	7.40	7.40	5.55	0.00	1.23	0.00	0.00
penis, adult	10200-103F2	16.11	6.98	8.06	5.37	0.00	3.22	1.61	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	2.42	13.02	5.02	1.86	0.00	0.00	0.93	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	28.41	10.20	12.97	2.19	0.44	1.60	0.44	2.19
pineal gland - adult, donor10196	10179-103C8	2.58	7.74	1.29	0.65	0.00	0.00	0.65	0.00
pineal gland, adult, donor10252	10160-103A7	2.96	18.36	1.78	1.78	0.00	0.00	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	1.88	11.29	0.63	1.25	0.00	1.25	0.00	0.63
pituitary gland - adult, donor10196	10180-103C9	1.01	2.02	2.02	2.02	0.00	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	8.86	6.25	0.52	0.52	0.00	0.00	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	6.81	9.36	0.00	2.55	0.00	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	6.67	6.45	1.51	0.43	0.22	0.22	0.22	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	4.11	4.11	1.59	2.12	0.00	0.40	0.40	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	27.70	13.23	6.85	3.42	0.16	1.25	0.16	0.62
pons, adult, pool1	10033-101E6	3.01	2.07	0.60	0.00	0.00	0.26	0.09	0.00
postcentral gyrus, adult, pool1	10032-101E5	6.71	4.79	2.01	0.35	0.09	0.26	0.09	0.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	14.64	31.37	12.55	2.09	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	5.51	5.51	5.51	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	11.74	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	20.25	16.90	7.87	2.04	2.33	2.18	0.29	1.46
prostate cancer cell line:PC-3	10439-106E7	29.22	17.61	30.67	2.72	1.09	5.08	0.91	1.27
prostate, adult, pool1	10022-101D4	18.50	15.87	4.26	1.45	0.54	1.63	0.45	1.09
putamen, adult, donor10196	10176-103C5	2.60	2.12	1.65	0.24	0.00	1.42	0.47	0.00
putamen, adult, donor10252	10152-102I8	11.76	0.00	0.00	0.00	0.00	1.96	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	1.09	1.09	0.00	1.09	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	1.93	2.17	0.72	0.48	0.00	0.24	0.24	0.24
putamen, newborn, donor10223	10365-105F5	0.75	2.25	0.00	1.50	0.00	0.00	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	8.44	17.17	5.24	0.29	0.29	0.58	0.29	0.29
rectum, fetal, donor1	10067-101I4	16.69	4.17	19.47	1.39	0.00	1.39	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	8.90	15.48	13.78	1.91	2.33	1.27	0.00	0.64
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	6.21	10.36	9.53	1.66	2.07	0.41	0.00	0.41
retina, adult, pool1	10030-101E3	14.61	14.51	4.27	0.50	0.00	1.19	0.30	0.70
retinoblastoma cell line:Y79	10475-106I7	8.31	7.01	3.38	2.08	0.26	0.00	0.00	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	11.68	9.84	6.15	0.74	0.00	0.49	0.37	0.74
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	15.75	32.34	24.46	3.37	2.53	0.84	0.28	1.12
sacrococcigeal teratoma cell line:HTST	10695-109G2	14.40	14.40	14.40	0.00	0.00	0.76	0.76	0.00
salivary acinar cells, donor1	11771-123I7	10.84	13.92	11.49	0.81	0.16	1.46	0.65	3.08
salivary acinar cells, donor2	11772-123I8	15.15	20.52	22.58	7.57	0.55	2.89	2.48	2.20
salivary acinar cells, donor3	11773-123I9	16.55	14.57	11.92	2.65	0.66	0.66	0.00	1.32
salivary gland, adult, pool1	10093-102C3	3.43	12.01	1.72	0.57	0.00	0.57	0.00	2.29
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	4.47	10.12	4.05	0.17	0.17	0.93	0.17	2.36
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	6.35	9.29	4.11	0.59	0.24	0.94	0.00	1.65
seminal vesicle, adult	10201-103F3	7.94	14.81	4.76	3.17	0.53	1.06	2.12	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	23.32	11.42	7.53	17.00	0.97	3.16	2.92	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	17.61	5.03	3.52	9.81	0.00	0.75	0.50	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	16.06	10.04	20.07	28.10	1.00	2.01	2.01	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	30.22	31.97	25.25	6.58	49.43	4.16	2.15	5.64
signet ring carcinoma cell line:Kato III	10436-106E4	6.52	26.86	6.74	1.22	0.77	1.22	0.00	0.33
signet ring carcinoma cell line:NUGC-4	10483-107A6	8.13	14.71	14.19	2.06	6.19	4.39	0.65	0.90
skeletal muscle - soleus muscle, donor1	10282-104F3	19.15	11.35	0.71	4.97	0.00	4.97	0.00	4.97
skeletal muscle, adult, pool1	10023-101D5	21.83	6.12	1.44	1.20	0.12	2.64	0.36	6.12
skeletal muscle, fetal, donor1	10066-101I3	40.20	10.05	18.09	5.03	0.00	3.02	0.00	1.01
skin, adult, donor1	10074-102A2	27.14	0.00	13.57	0.00	0.00	6.79	0.00	0.00
skin, fetal, donor1	10065-101I2	14.52	10.73	15.15	1.89	0.63	1.26	0.00	2.52
small cell cervical cancer cell line:HCSC-1	10800-110I8	45.36	11.34	14.68	1.00	0.00	1.00	1.33	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	5.67	10.72	10.40	5.99	0.95	0.63	0.00	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	30.26	37.39	7.52	10.41	0.39	0.39	1.93	0.39
small cell lung carcinoma cell line:LK-2	10541-107H1	4.29	5.93	2.97	0.33	0.49	0.49	0.33	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	5.15	10.29	8.85	1.13	0.32	0.16	0.64	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	13.95	13.29	14.82	2.83	0.00	1.53	0.44	0.00
small intestine, adult, pool1	10024-101D6	12.42	4.06	1.79	0.84	0.00	0.48	0.48	0.24
small intestine, fetal, donor1	10064-101I1	11.30	5.16	6.39	1.97	0.00	1.23	0.98	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	3.08	7.69	5.64	6.15	0.00	0.51	0.51	0.00
smooth muscle, adult, pool1	10048-101G3	20.42	16.28	6.72	5.17	0.00	0.78	3.10	0.26
somatostatinoma cell line:QGP-1	10781-110G7	4.56	9.38	5.09	0.00	0.00	0.54	0.54	0.00
spinal cord - adult, donor10196	10181-103D1	4.13	2.06	0.92	1.38	0.00	0.46	0.00	0.23
spinal cord, adult, donor10252	10159-103A6	5.13	1.58	1.18	0.79	0.00	0.00	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	0.00	1.38	0.00	3.46	0.00	0.69	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	11.59	4.88	4.27	3.05	0.61	1.22	0.00	0.61
spinal cord, newborn, donor10223	10359-105E8	1.84	1.38	1.84	2.30	0.00	0.46	0.00	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	18.82	13.89	18.22	1.94	0.00	2.09	0.15	0.15
spleen, adult, pool1	10025-101D7	8.37	4.52	3.08	0.55	0.11	1.76	0.33	0.11
spleen, fetal, pool1	10044-101F8	11.28	5.72	8.26	0.72	0.64	2.54	0.72	0.16
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	1.45	0.52	0.00	0.41	0.00	0.00	0.10	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	10.63	11.77	7.41	0.76	0.00	0.95	0.00	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	17.12	23.06	5.59	8.39	0.00	1.75	1.75	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	5.08	15.25	8.21	5.47	0.00	0.78	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	10.81	20.37	6.53	1.13	0.45	0.90	0.23	1.24
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	11.01	11.01	4.66	4.66	0.85	2.54	0.85	3.39
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	5.50	2.12	1.69	0.85	0.00	1.27	0.00	0.00
stomach, fetal, donor1	10062-101H8	10.68	2.14	10.68	1.07	1.07	1.07	0.00	0.00
submaxillary gland, adult	10202-103F4	17.66	8.55	3.99	5.13	0.00	1.71	0.00	2.28
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	8.10	2.08	0.83	0.62	0.00	0.62	0.42	0.00
substantia nigra, adult, donor10258	10371-105G2	1.55	2.59	0.52	2.07	0.00	0.00	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	1.41	2.83	0.71	0.71	0.00	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	22.01	17.42	16.51	1.15	0.23	0.92	0.46	0.69
temporal lobe, adult, pool1	10031-101E4	5.59	5.17	1.78	0.42	0.08	0.25	0.42	0.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	0.71	3.56	5.70	1.42	0.00	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	0.88	6.15	3.52	2.20	0.00	0.00	0.00	0.00
tenocyte, donor1	11763-123H8	31.42	22.34	17.11	16.76	0.35	1.75	1.75	2.09
tenocyte, donor2	11765-123I1	21.75	13.35	9.92	9.16	0.76	1.53	1.53	1.14
tenocyte, donor3	11768-123I4	19.65	20.39	14.46	20.39	0.74	3.71	3.34	2.97
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	6.97	7.65	4.93	1.02	0.00	0.85	0.17	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	34.68	17.88	20.35	6.47	0.46	2.00	1.54	0.31
teratocarcinoma cell line:PA-1	10807-111A6	11.78	6.97	7.13	0.62	0.00	1.70	0.31	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	3.81	1.27	0.76	0.00	0.13	0.63	0.13	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	2.65	12.86	4.92	0.76	0.00	0.38	1.13	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	2.29	6.33	2.51	0.55	0.00	0.44	0.11	0.22
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	2.93	2.61	2.93	2.61	0.00	0.00	0.33	0.00
testis, adult, pool1	10026-101D8	13.96	16.86	5.58	2.90	0.43	0.97	1.40	0.43
testis, adult, pool2	10096-102C6	7.22	22.10	6.77	7.67	0.00	0.90	3.16	0.00
thalamus - adult, donor10196	10168-103B6	1.10	2.21	2.21	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	4.53	2.03	0.47	1.41	0.00	0.16	0.16	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	0.00	1.54	3.08	1.54	0.00	0.00	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	2.96	1.65	0.82	1.98	0.00	0.16	0.16	0.00
thalamus, newborn, donor10223	10366-105F6	0.00	1.73	1.15	3.45	0.00	0.00	0.00	0.00
throat, adult	10209-103G2	14.23	9.24	4.49	6.49	0.00	2.00	0.00	1.75
throat, fetal, donor1	10061-101H7	18.59	5.79	10.97	5.79	0.91	2.13	0.61	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	12.52	15.10	10.14	3.78	0.99	0.00	0.40	2.38
thymus, adult, pool1	10027-101D9	6.36	2.78	5.96	0.70	0.00	0.50	0.30	0.50
thymus, fetal, pool1	10043-101F7	7.38	6.55	9.35	0.31	0.31	0.31	0.62	0.31
thyroid carcinoma cell line:KHM-5M	10776-110G2	13.16	17.15	25.26	8.64	0.13	2.13	1.33	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	14.11	12.71	9.22	0.84	0.28	0.70	0.14	0.28
thyroid, adult, pool1	10028-101E1	7.93	6.25	1.96	0.56	0.09	1.03	0.19	0.19
thyroid, fetal, donor1	10060-101H6	15.29	7.38	9.49	3.43	0.00	1.58	0.53	1.05
tongue epidermis (fungiform papillae), donor1	10288-104F9	9.24	3.08	12.32	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	15.58	8.37	2.33	9.77	0.00	1.86	1.63	3.72
tongue, fetal, donor1	10059-101H5	33.10	5.52	6.31	7.88	0.00	2.36	0.79	2.76
tonsil, adult, pool1	10047-101G2	16.13	12.52	7.61	0.50	0.00	0.70	0.50	0.90
trachea, adult, pool1	10029-101E2	9.08	3.93	2.78	0.41	0.33	0.74	0.16	0.08
trachea, fetal, donor1	10058-101H4	15.39	8.85	5.39	1.15	0.77	2.31	0.00	1.54
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	10.98	8.86	30.11	2.13	1.06	2.13	0.35	2.83
transitional-cell carcinoma cell line:5637	10418-106C4	12.66	10.13	3.55	0.71	0.61	0.71	0.30	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	16.61	17.71	8.93	3.45	1.10	2.04	0.63	1.57
tridermal teratoma cell line:HGRT	10694-109G1	13.32	13.32	19.03	0.00	1.90	1.90	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	12.53	7.87	6.69	0.85	1.10	2.20	0.59	0.34
umbilical cord, fetal, donor1	10057-101H3	10.43	14.61	14.61	2.09	0.00	0.00	8.35	0.00
uterus, adult, pool1	10100-102D1	5.63	10.75	5.29	0.51	0.34	0.34	0.17	0.17
uterus, fetal, donor1	10055-101H1	16.89	7.17	10.75	1.02	0.00	1.54	0.51	0.51
vagina, adult	10204-103F6	4.52	5.17	0.00	1.94	0.00	0.65	0.00	0.00
vein, adult	10191-103E2	10.30	8.77	6.14	4.16	0.00	2.41	0.44	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	2.14	1.07	0.00	0.53	0.00	0.00	0.27	0.00